| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 346 | 2024 | 21157 | 8.970 |
Why?
|
| Breast Diseases | 28 | 2019 | 443 | 5.350 |
Why?
|
| Mammography | 53 | 2024 | 2436 | 4.680 |
Why?
|
| Obesity | 148 | 2023 | 13065 | 4.630 |
Why?
|
| Neoplasms | 121 | 2024 | 22389 | 3.550 |
Why?
|
| Diet | 134 | 2024 | 8098 | 3.240 |
Why?
|
| Breast | 47 | 2024 | 1976 | 3.200 |
Why?
|
| Smoking | 145 | 2020 | 9099 | 2.960 |
Why?
|
| Alcohol Drinking | 90 | 2019 | 4052 | 2.930 |
Why?
|
| Risk Factors | 572 | 2024 | 74915 | 2.870 |
Why?
|
| Exercise | 95 | 2021 | 5940 | 2.860 |
Why?
|
| Body Mass Index | 176 | 2022 | 13030 | 2.820 |
Why?
|
| Estrogen Replacement Therapy | 53 | 2018 | 1209 | 2.710 |
Why?
|
| Nurses | 105 | 2020 | 2494 | 2.580 |
Why?
|
| Weight Gain | 48 | 2024 | 2357 | 2.500 |
Why?
|
| Body Weight | 73 | 2019 | 4630 | 2.470 |
Why?
|
| Premenopause | 45 | 2024 | 1039 | 2.460 |
Why?
|
| Female | 1022 | 2024 | 396926 | 2.430 |
Why?
|
| Humans | 1316 | 2024 | 768369 | 2.350 |
Why?
|
| Postmenopause | 89 | 2022 | 2519 | 2.300 |
Why?
|
| Estrogens | 36 | 2015 | 1531 | 2.220 |
Why?
|
| Multiple Myeloma | 31 | 2024 | 5193 | 2.160 |
Why?
|
| Receptors, Progesterone | 31 | 2019 | 1145 | 2.110 |
Why?
|
| Risk Assessment | 128 | 2024 | 24310 | 2.060 |
Why?
|
| Middle Aged | 770 | 2024 | 223406 | 2.010 |
Why?
|
| Adult | 722 | 2024 | 223528 | 1.900 |
Why?
|
| Receptors, Estrogen | 37 | 2024 | 2243 | 1.890 |
Why?
|
| Dietary Fats | 48 | 2014 | 2003 | 1.890 |
Why?
|
| Early Detection of Cancer | 32 | 2024 | 3230 | 1.830 |
Why?
|
| Prospective Studies | 440 | 2024 | 54913 | 1.830 |
Why?
|
| United States | 381 | 2024 | 73120 | 1.810 |
Why?
|
| Feeding Behavior | 45 | 2019 | 3202 | 1.810 |
Why?
|
| Adiposity | 15 | 2022 | 1888 | 1.790 |
Why?
|
| Risk | 135 | 2023 | 9642 | 1.790 |
Why?
|
| Models, Statistical | 36 | 2024 | 5103 | 1.780 |
Why?
|
| Cohort Studies | 292 | 2024 | 41782 | 1.730 |
Why?
|
| Health Promotion | 25 | 2019 | 2215 | 1.680 |
Why?
|
| Overweight | 20 | 2021 | 2428 | 1.640 |
Why?
|
| Fibrocystic Breast Disease | 9 | 2013 | 103 | 1.610 |
Why?
|
| Life Style | 57 | 2024 | 3929 | 1.610 |
Why?
|
| Women's Health | 31 | 2016 | 2079 | 1.590 |
Why?
|
| Diabetes, Gestational | 12 | 2022 | 1259 | 1.580 |
Why?
|
| Colonic Neoplasms | 36 | 2020 | 2544 | 1.550 |
Why?
|
| Carcinoma, Ductal, Breast | 11 | 2022 | 1092 | 1.500 |
Why?
|
| Colorectal Neoplasms | 61 | 2023 | 6979 | 1.480 |
Why?
|
| Risk Reduction Behavior | 11 | 2020 | 1120 | 1.470 |
Why?
|
| Research Design | 36 | 2024 | 6217 | 1.450 |
Why?
|
| Evidence-Based Medicine | 12 | 2018 | 3708 | 1.450 |
Why?
|
| Mass Screening | 36 | 2024 | 5455 | 1.450 |
Why?
|
| Weight Loss | 33 | 2021 | 2710 | 1.440 |
Why?
|
| Coronary Disease | 76 | 2015 | 5926 | 1.410 |
Why?
|
| Randomized Controlled Trials as Topic | 33 | 2023 | 10358 | 1.360 |
Why?
|
| Aged | 378 | 2024 | 171514 | 1.340 |
Why?
|
| Contraceptives, Oral | 28 | 2021 | 562 | 1.340 |
Why?
|
| Adolescent Behavior | 20 | 2008 | 1192 | 1.320 |
Why?
|
| Motor Activity | 18 | 2014 | 2722 | 1.280 |
Why?
|
| Incidence | 186 | 2024 | 21552 | 1.270 |
Why?
|
| Leisure Activities | 12 | 2014 | 310 | 1.250 |
Why?
|
| Health Surveys | 42 | 2018 | 4056 | 1.230 |
Why?
|
| Carotenoids | 21 | 2017 | 621 | 1.220 |
Why?
|
| Health Behavior | 32 | 2021 | 2649 | 1.170 |
Why?
|
| Bulimia | 12 | 2004 | 405 | 1.160 |
Why?
|
| Neoplasms, Second Primary | 4 | 2021 | 1062 | 1.150 |
Why?
|
| Monoclonal Gammopathy of Undetermined Significance | 7 | 2024 | 179 | 1.130 |
Why?
|
| Progestins | 14 | 2007 | 302 | 1.110 |
Why?
|
| Proportional Hazards Models | 81 | 2024 | 12561 | 1.100 |
Why?
|
| Primary Prevention | 7 | 2018 | 1189 | 1.100 |
Why?
|
| Meta-Analysis as Topic | 23 | 2019 | 1364 | 1.100 |
Why?
|
| Odds Ratio | 76 | 2023 | 9687 | 1.100 |
Why?
|
| Dietary Fiber | 28 | 2014 | 767 | 1.090 |
Why?
|
| Adolescent | 174 | 2024 | 89163 | 1.090 |
Why?
|
| Smoking Cessation | 23 | 2022 | 2078 | 1.080 |
Why?
|
| Dairy Products | 11 | 2020 | 490 | 1.060 |
Why?
|
| Public Health | 17 | 2023 | 2693 | 1.060 |
Why?
|
| Follow-Up Studies | 182 | 2022 | 39429 | 1.050 |
Why?
|
| Survivors | 17 | 2021 | 2379 | 1.040 |
Why?
|
| Lung Neoplasms | 42 | 2022 | 13589 | 1.040 |
Why?
|
| Energy Intake | 41 | 2015 | 2141 | 1.020 |
Why?
|
| Hip Fractures | 14 | 2003 | 996 | 1.020 |
Why?
|
| Case-Control Studies | 122 | 2024 | 22286 | 1.020 |
Why?
|
| Menarche | 20 | 2016 | 538 | 1.020 |
Why?
|
| Biometry | 5 | 2018 | 565 | 1.010 |
Why?
|
| Healthcare Disparities | 14 | 2024 | 3412 | 1.010 |
Why?
|
| Calcium, Dietary | 16 | 2020 | 533 | 1.000 |
Why?
|
| Epidemiologic Studies | 12 | 2016 | 681 | 1.000 |
Why?
|
| Vegetables | 30 | 2024 | 1202 | 1.000 |
Why?
|
| Diabetes Mellitus, Type 2 | 56 | 2024 | 12242 | 1.000 |
Why?
|
| Menopause | 46 | 2016 | 1650 | 0.990 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 8 | 2024 | 934 | 0.990 |
Why?
|
| Fruit | 29 | 2024 | 1165 | 0.980 |
Why?
|
| Adolescent Nutritional Physiological Phenomena | 8 | 2005 | 62 | 0.960 |
Why?
|
| Missouri | 14 | 2023 | 115 | 0.960 |
Why?
|
| Male | 396 | 2024 | 364761 | 0.960 |
Why?
|
| Indians, North American | 8 | 2018 | 354 | 0.940 |
Why?
|
| Age Factors | 106 | 2021 | 18477 | 0.920 |
Why?
|
| Cluster Analysis | 9 | 2023 | 2730 | 0.910 |
Why?
|
| Biomedical Research | 12 | 2021 | 3463 | 0.910 |
Why?
|
| Cystitis, Interstitial | 9 | 2020 | 66 | 0.910 |
Why?
|
| Interdisciplinary Communication | 5 | 2015 | 937 | 0.910 |
Why?
|
| Folic Acid | 19 | 2012 | 1336 | 0.910 |
Why?
|
| Prostatic Neoplasms | 34 | 2023 | 11206 | 0.900 |
Why?
|
| Anticarcinogenic Agents | 5 | 2014 | 251 | 0.890 |
Why?
|
| Diet Surveys | 36 | 2021 | 1161 | 0.870 |
Why?
|
| Aspirin | 18 | 2022 | 3139 | 0.870 |
Why?
|
| Life Expectancy | 8 | 2017 | 1249 | 0.870 |
Why?
|
| Research Personnel | 6 | 2021 | 591 | 0.870 |
Why?
|
| Multivariate Analysis | 128 | 2020 | 12096 | 0.860 |
Why?
|
| Patient Acceptance of Health Care | 11 | 2022 | 3237 | 0.850 |
Why?
|
| Cause of Death | 18 | 2024 | 3727 | 0.840 |
Why?
|
| SEER Program | 12 | 2024 | 1476 | 0.840 |
Why?
|
| Poverty | 13 | 2019 | 2719 | 0.830 |
Why?
|
| Television | 11 | 2019 | 410 | 0.830 |
Why?
|
| Nutrition Assessment | 15 | 2019 | 740 | 0.830 |
Why?
|
| Precancerous Conditions | 10 | 2017 | 988 | 0.830 |
Why?
|
| Health Literacy | 3 | 2020 | 467 | 0.810 |
Why?
|
| Sunburn | 15 | 2015 | 156 | 0.810 |
Why?
|
| Public Health Practice | 3 | 2017 | 221 | 0.810 |
Why?
|
| Community-Based Participatory Research | 5 | 2020 | 223 | 0.800 |
Why?
|
| Breast Feeding | 13 | 2016 | 1365 | 0.800 |
Why?
|
| Hormone Replacement Therapy | 9 | 2009 | 756 | 0.800 |
Why?
|
| Body Image | 11 | 2008 | 644 | 0.790 |
Why?
|
| Eating | 11 | 2018 | 1538 | 0.780 |
Why?
|
| Epidemiologic Methods | 21 | 2010 | 1337 | 0.780 |
Why?
|
| Child Nutritional Physiological Phenomena | 7 | 2005 | 294 | 0.770 |
Why?
|
| Data Interpretation, Statistical | 10 | 2021 | 2705 | 0.770 |
Why?
|
| Longitudinal Studies | 55 | 2022 | 14766 | 0.770 |
Why?
|
| Insulin-Like Growth Factor I | 11 | 2012 | 1943 | 0.770 |
Why?
|
| Pelvic Pain | 6 | 2020 | 298 | 0.760 |
Why?
|
| Sunscreening Agents | 8 | 2015 | 139 | 0.760 |
Why?
|
| Vitamin E | 18 | 2006 | 873 | 0.760 |
Why?
|
| Information Dissemination | 9 | 2021 | 1138 | 0.750 |
Why?
|
| Health Status Disparities | 8 | 2023 | 1876 | 0.740 |
Why?
|
| Population Surveillance | 18 | 2020 | 2601 | 0.740 |
Why?
|
| Intensive Care Units, Neonatal | 6 | 2021 | 861 | 0.730 |
Why?
|
| Body Height | 23 | 2018 | 1568 | 0.730 |
Why?
|
| Chronic Disease | 24 | 2020 | 9379 | 0.730 |
Why?
|
| Vitamin A | 16 | 2006 | 611 | 0.720 |
Why?
|
| Child | 109 | 2024 | 80856 | 0.720 |
Why?
|
| Birth Weight | 11 | 2017 | 2117 | 0.710 |
Why?
|
| Diabetes Mellitus | 22 | 2024 | 5887 | 0.710 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 3 | 2022 | 79 | 0.710 |
Why?
|
| Bariatric Surgery | 3 | 2017 | 1007 | 0.690 |
Why?
|
| Body Size | 3 | 2021 | 463 | 0.690 |
Why?
|
| Sample Size | 7 | 2023 | 851 | 0.690 |
Why?
|
| Hysterectomy | 9 | 2011 | 863 | 0.690 |
Why?
|
| Logistic Models | 70 | 2021 | 13323 | 0.680 |
Why?
|
| Carcinoma, Lobular | 4 | 2019 | 480 | 0.680 |
Why?
|
| Cost of Illness | 10 | 2020 | 1960 | 0.670 |
Why?
|
| Prostatitis | 6 | 2020 | 102 | 0.670 |
Why?
|
| Mass Media | 5 | 2005 | 304 | 0.660 |
Why?
|
| Endometrial Neoplasms | 14 | 2023 | 1382 | 0.660 |
Why?
|
| Polymorphism, Genetic | 32 | 2008 | 4247 | 0.660 |
Why?
|
| Postnatal Care | 2 | 2019 | 273 | 0.650 |
Why?
|
| Postpartum Period | 4 | 2022 | 1197 | 0.650 |
Why?
|
| Community Networks | 4 | 2015 | 202 | 0.640 |
Why?
|
| Adipose Tissue | 18 | 2017 | 3335 | 0.640 |
Why?
|
| Skin Neoplasms | 31 | 2016 | 5891 | 0.640 |
Why?
|
| Parity | 30 | 2013 | 939 | 0.640 |
Why?
|
| Behavioral Medicine | 1 | 2019 | 49 | 0.630 |
Why?
|
| Physical Exertion | 7 | 2008 | 669 | 0.630 |
Why?
|
| Health Knowledge, Attitudes, Practice | 11 | 2018 | 4049 | 0.630 |
Why?
|
| Body Constitution | 15 | 2000 | 273 | 0.620 |
Why?
|
| Diet Records | 15 | 2007 | 427 | 0.620 |
Why?
|
| Regression Analysis | 37 | 2024 | 6353 | 0.620 |
Why?
|
| Neoplasm Recurrence, Local | 16 | 2022 | 9425 | 0.620 |
Why?
|
| Cooperative Behavior | 7 | 2016 | 1514 | 0.620 |
Why?
|
| Milk | 8 | 2018 | 445 | 0.610 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 12 | 2022 | 2279 | 0.610 |
Why?
|
| Pregnancy | 54 | 2022 | 30179 | 0.610 |
Why?
|
| Geriatric Assessment | 4 | 2019 | 1422 | 0.600 |
Why?
|
| Research | 7 | 2017 | 1984 | 0.590 |
Why?
|
| Bibliometrics | 2 | 2013 | 354 | 0.590 |
Why?
|
| Neoplasms, Radiation-Induced | 4 | 2015 | 555 | 0.580 |
Why?
|
| Confidence Intervals | 46 | 2020 | 2932 | 0.580 |
Why?
|
| Research Support as Topic | 4 | 2020 | 699 | 0.580 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 12 | 2020 | 5426 | 0.570 |
Why?
|
| Infant, Premature | 4 | 2021 | 2124 | 0.570 |
Why?
|
| Dietary Supplements | 17 | 2009 | 3445 | 0.570 |
Why?
|
| Child Development | 6 | 2021 | 2328 | 0.570 |
Why?
|
| Coffee | 12 | 2018 | 598 | 0.560 |
Why?
|
| Health Policy | 14 | 2020 | 2699 | 0.560 |
Why?
|
| Diet, Reducing | 7 | 2012 | 487 | 0.560 |
Why?
|
| Socioeconomic Factors | 29 | 2023 | 7863 | 0.560 |
Why?
|
| Adenoma | 23 | 2011 | 2163 | 0.560 |
Why?
|
| Selective Estrogen Receptor Modulators | 4 | 2008 | 131 | 0.560 |
Why?
|
| Peer Group | 7 | 2020 | 697 | 0.550 |
Why?
|
| Counseling | 9 | 2021 | 1548 | 0.550 |
Why?
|
| RANK Ligand | 1 | 2018 | 321 | 0.550 |
Why?
|
| Time Factors | 88 | 2021 | 40271 | 0.550 |
Why?
|
| Hyperplasia | 10 | 2015 | 1154 | 0.550 |
Why?
|
| Caffeine | 11 | 2019 | 702 | 0.550 |
Why?
|
| Cardiovascular Diseases | 44 | 2023 | 15638 | 0.550 |
Why?
|
| Neoplasm Staging | 26 | 2024 | 11249 | 0.550 |
Why?
|
| Professional-Patient Relations | 2 | 2020 | 727 | 0.540 |
Why?
|
| Health Education | 6 | 2015 | 1059 | 0.540 |
Why?
|
| Social Support | 14 | 2018 | 2195 | 0.540 |
Why?
|
| Protective Clothing | 4 | 2011 | 103 | 0.540 |
Why?
|
| Food | 7 | 2021 | 770 | 0.530 |
Why?
|
| Quality of Life | 24 | 2023 | 13497 | 0.530 |
Why?
|
| Vitamin D | 16 | 2015 | 3311 | 0.530 |
Why?
|
| Young Adult | 54 | 2024 | 60038 | 0.530 |
Why?
|
| Body Fat Distribution | 2 | 2021 | 245 | 0.530 |
Why?
|
| Anastomotic Leak | 1 | 2017 | 171 | 0.530 |
Why?
|
| Computer Simulation | 5 | 2024 | 6278 | 0.530 |
Why?
|
| Nuts | 5 | 2024 | 265 | 0.530 |
Why?
|
| BCG Vaccine | 8 | 2001 | 383 | 0.520 |
Why?
|
| Internet | 12 | 2018 | 3123 | 0.520 |
Why?
|
| Polypharmacy | 1 | 2018 | 307 | 0.520 |
Why?
|
| Cholelithiasis | 13 | 2002 | 408 | 0.510 |
Why?
|
| Nutrition Surveys | 23 | 2022 | 1734 | 0.510 |
Why?
|
| Nursing Research | 1 | 2016 | 80 | 0.510 |
Why?
|
| Sunlight | 11 | 2015 | 337 | 0.510 |
Why?
|
| Health Status Indicators | 7 | 2008 | 971 | 0.500 |
Why?
|
| Mentors | 5 | 2021 | 672 | 0.500 |
Why?
|
| Adolescent Development | 2 | 2011 | 283 | 0.500 |
Why?
|
| Occupations | 4 | 2022 | 519 | 0.500 |
Why?
|
| Prognosis | 40 | 2024 | 30031 | 0.490 |
Why?
|
| Cross-Sectional Studies | 61 | 2024 | 26348 | 0.490 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 3 | 2015 | 1427 | 0.490 |
Why?
|
| Hormones | 9 | 2022 | 870 | 0.490 |
Why?
|
| Communicable Diseases | 3 | 2023 | 875 | 0.490 |
Why?
|
| Education, Continuing | 1 | 2015 | 114 | 0.480 |
Why?
|
| Periodicals as Topic | 7 | 2019 | 1468 | 0.480 |
Why?
|
| Mass Vaccination | 1 | 2016 | 110 | 0.480 |
Why?
|
| Postoperative Complications | 15 | 2021 | 15879 | 0.480 |
Why?
|
| Osteoporosis, Postmenopausal | 6 | 2011 | 399 | 0.480 |
Why?
|
| Comorbidity | 23 | 2020 | 10601 | 0.470 |
Why?
|
| Family Health | 6 | 2011 | 1256 | 0.470 |
Why?
|
| Sex Factors | 38 | 2023 | 10647 | 0.470 |
Why?
|
| Ascorbic Acid | 14 | 2007 | 658 | 0.470 |
Why?
|
| Rectal Neoplasms | 8 | 2020 | 1179 | 0.470 |
Why?
|
| Papillomavirus Vaccines | 2 | 2022 | 497 | 0.470 |
Why?
|
| Estrogens, Conjugated (USP) | 7 | 2011 | 277 | 0.470 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2019 | 451 | 0.470 |
Why?
|
| Social Class | 4 | 2010 | 2000 | 0.460 |
Why?
|
| Survival Analysis | 20 | 2024 | 10127 | 0.460 |
Why?
|
| Aged, 80 and over | 56 | 2024 | 59679 | 0.460 |
Why?
|
| Flail Chest | 1 | 2013 | 14 | 0.460 |
Why?
|
| Research Report | 3 | 2014 | 369 | 0.460 |
Why?
|
| Self Concept | 5 | 2008 | 1050 | 0.460 |
Why?
|
| Health Services Accessibility | 9 | 2023 | 5508 | 0.460 |
Why?
|
| Orthopedics | 2 | 2022 | 906 | 0.460 |
Why?
|
| Capacity Building | 2 | 2013 | 265 | 0.460 |
Why?
|
| Aging, Premature | 2 | 2024 | 44 | 0.450 |
Why?
|
| Staff Development | 1 | 2015 | 230 | 0.440 |
Why?
|
| Primary Health Care | 9 | 2020 | 4736 | 0.440 |
Why?
|
| American Medical Association | 1 | 2013 | 60 | 0.440 |
Why?
|
| Decision Making | 7 | 2016 | 3961 | 0.440 |
Why?
|
| Epidemiology | 6 | 2020 | 280 | 0.440 |
Why?
|
| Thoracic Surgery | 2 | 2019 | 727 | 0.440 |
Why?
|
| Meat | 16 | 2017 | 586 | 0.440 |
Why?
|
| Neoplasms, Hormone-Dependent | 8 | 2011 | 410 | 0.440 |
Why?
|
| Patient Selection | 5 | 2013 | 4266 | 0.430 |
Why?
|
| Ovarian Neoplasms | 22 | 2017 | 4906 | 0.430 |
Why?
|
| Occupational Exposure | 6 | 2022 | 1818 | 0.430 |
Why?
|
| Tobacco Smoke Pollution | 6 | 2012 | 828 | 0.430 |
Why?
|
| Environmental Exposure | 10 | 2019 | 4533 | 0.430 |
Why?
|
| Pancreatic Neoplasms | 15 | 2014 | 5443 | 0.430 |
Why?
|
| Interleukin-6 | 3 | 2016 | 3234 | 0.420 |
Why?
|
| Observer Variation | 1 | 2019 | 2622 | 0.420 |
Why?
|
| Evaluation Studies as Topic | 11 | 2008 | 1629 | 0.420 |
Why?
|
| Work Schedule Tolerance | 5 | 2006 | 553 | 0.420 |
Why?
|
| Tissue and Organ Procurement | 2 | 2023 | 983 | 0.420 |
Why?
|
| Tamoxifen | 6 | 2017 | 968 | 0.420 |
Why?
|
| Preventive Medicine | 3 | 2017 | 245 | 0.420 |
Why?
|
| Insurance Coverage | 3 | 2020 | 1946 | 0.420 |
Why?
|
| Plant Oils | 2 | 2013 | 199 | 0.410 |
Why?
|
| Beverages | 6 | 2005 | 822 | 0.410 |
Why?
|
| Medicaid | 6 | 2022 | 2843 | 0.410 |
Why?
|
| Anthracyclines | 1 | 2015 | 286 | 0.410 |
Why?
|
| Biopsy | 18 | 2019 | 6816 | 0.410 |
Why?
|
| Hypertension | 34 | 2020 | 8610 | 0.410 |
Why?
|
| Dietary Carbohydrates | 10 | 2008 | 896 | 0.410 |
Why?
|
| Databases, Bibliographic | 2 | 2019 | 130 | 0.410 |
Why?
|
| Community Health Centers | 2 | 2013 | 469 | 0.400 |
Why?
|
| Patient Education as Topic | 6 | 2013 | 2339 | 0.400 |
Why?
|
| Attitude to Health | 11 | 2013 | 2030 | 0.400 |
Why?
|
| Rib Fractures | 1 | 2013 | 129 | 0.400 |
Why?
|
| Age Distribution | 27 | 2015 | 2881 | 0.400 |
Why?
|
| Obesity, Morbid | 3 | 2021 | 1309 | 0.400 |
Why?
|
| Neoplasm Invasiveness | 13 | 2022 | 3637 | 0.400 |
Why?
|
| Self-Assessment | 3 | 2005 | 402 | 0.400 |
Why?
|
| Genetic Predisposition to Disease | 36 | 2023 | 18047 | 0.390 |
Why?
|
| Occupational Health | 7 | 2019 | 814 | 0.390 |
Why?
|
| Activities of Daily Living | 4 | 2018 | 2433 | 0.390 |
Why?
|
| Computer-Assisted Instruction | 4 | 2004 | 364 | 0.390 |
Why?
|
| Version, Fetal | 1 | 2011 | 22 | 0.390 |
Why?
|
| Reproductive History | 10 | 2016 | 210 | 0.390 |
Why?
|
| Risk-Taking | 5 | 2007 | 1041 | 0.390 |
Why?
|
| Preventive Health Services | 5 | 2013 | 568 | 0.380 |
Why?
|
| Clinical Trials as Topic | 16 | 2013 | 8051 | 0.380 |
Why?
|
| Family | 7 | 2012 | 3208 | 0.380 |
Why?
|
| Image Cytometry | 1 | 2011 | 53 | 0.380 |
Why?
|
| Health Status | 15 | 2015 | 4096 | 0.380 |
Why?
|
| Prevalence | 46 | 2020 | 15879 | 0.380 |
Why?
|
| Social Environment | 1 | 2016 | 1026 | 0.380 |
Why?
|
| Veterans | 8 | 2024 | 2671 | 0.380 |
Why?
|
| Surgical Wound Infection | 5 | 2020 | 1544 | 0.380 |
Why?
|
| National Cancer Institute (U.S.) | 6 | 2017 | 300 | 0.380 |
Why?
|
| Reproducibility of Results | 46 | 2019 | 20232 | 0.370 |
Why?
|
| Persuasive Communication | 3 | 2008 | 58 | 0.370 |
Why?
|
| alpha-Linolenic Acid | 5 | 2014 | 144 | 0.370 |
Why?
|
| Salpingectomy | 1 | 2011 | 45 | 0.370 |
Why?
|
| Melanoma | 19 | 2009 | 5740 | 0.370 |
Why?
|
| Ploidies | 1 | 2011 | 287 | 0.370 |
Why?
|
| Pamphlets | 1 | 2011 | 71 | 0.370 |
Why?
|
| Cholecystectomy | 9 | 2003 | 409 | 0.370 |
Why?
|
| Policy Making | 4 | 2012 | 545 | 0.360 |
Why?
|
| American Cancer Society | 2 | 2013 | 69 | 0.360 |
Why?
|
| Biological Specimen Banks | 5 | 2022 | 783 | 0.360 |
Why?
|
| Health Services Research | 2 | 2008 | 1815 | 0.360 |
Why?
|
| Observation | 2 | 2010 | 311 | 0.360 |
Why?
|
| Body Composition | 12 | 2020 | 2455 | 0.350 |
Why?
|
| Food Services | 2 | 2004 | 209 | 0.350 |
Why?
|
| Forearm Injuries | 5 | 1998 | 68 | 0.350 |
Why?
|
| Minority Groups | 3 | 2015 | 1215 | 0.350 |
Why?
|
| Cerebrovascular Disorders | 20 | 1999 | 1487 | 0.350 |
Why?
|
| Colonoscopy | 11 | 2014 | 1412 | 0.350 |
Why?
|
| Respiratory Tract Diseases | 2 | 2010 | 749 | 0.350 |
Why?
|
| Medical Oncology | 3 | 2020 | 2347 | 0.350 |
Why?
|
| Gonadal Steroid Hormones | 10 | 2007 | 708 | 0.340 |
Why?
|
| Survival Rate | 22 | 2019 | 12875 | 0.340 |
Why?
|
| Mortality | 11 | 2020 | 2917 | 0.340 |
Why?
|
| Prostatectomy | 7 | 2023 | 1840 | 0.340 |
Why?
|
| Xanthophylls | 4 | 2008 | 95 | 0.340 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 2 | 2010 | 208 | 0.330 |
Why?
|
| Program Development | 7 | 2018 | 1296 | 0.330 |
Why?
|
| Hematologic Neoplasms | 2 | 2023 | 1905 | 0.330 |
Why?
|
| Health Personnel | 21 | 2021 | 3384 | 0.330 |
Why?
|
| Rotator Cuff | 3 | 2022 | 349 | 0.330 |
Why?
|
| Dietary Proteins | 14 | 2005 | 960 | 0.330 |
Why?
|
| Anthropometry | 16 | 2014 | 1343 | 0.330 |
Why?
|
| Publishing | 3 | 2013 | 836 | 0.320 |
Why?
|
| Lutein | 4 | 2008 | 123 | 0.320 |
Why?
|
| Adenocarcinoma | 6 | 2023 | 6400 | 0.320 |
Why?
|
| Self Report | 9 | 2024 | 3771 | 0.320 |
Why?
|
| Treatment Outcome | 38 | 2022 | 65408 | 0.320 |
Why?
|
| Behavior Therapy | 4 | 2016 | 885 | 0.320 |
Why?
|
| Mental Recall | 12 | 2006 | 1226 | 0.320 |
Why?
|
| Cesarean Section | 4 | 2020 | 1414 | 0.320 |
Why?
|
| Carcinoma | 7 | 2011 | 2341 | 0.320 |
Why?
|
| Group Processes | 2 | 2020 | 228 | 0.320 |
Why?
|
| Mothers | 7 | 2016 | 2210 | 0.320 |
Why?
|
| Aromatase | 5 | 2016 | 147 | 0.320 |
Why?
|
| Health Care Costs | 8 | 2021 | 3266 | 0.310 |
Why?
|
| Rural Health | 5 | 2022 | 300 | 0.310 |
Why?
|
| Ovariectomy | 1 | 2011 | 614 | 0.310 |
Why?
|
| Vitamin B 12 | 2 | 2009 | 527 | 0.310 |
Why?
|
| Reproductive Behavior | 1 | 2008 | 27 | 0.310 |
Why?
|
| Decision Support Techniques | 3 | 2015 | 2010 | 0.310 |
Why?
|
| Patient Participation | 3 | 2013 | 1450 | 0.310 |
Why?
|
| Erectile Dysfunction | 3 | 2023 | 445 | 0.310 |
Why?
|
| Prenatal Care | 5 | 2020 | 1159 | 0.310 |
Why?
|
| Health Planning | 2 | 2011 | 233 | 0.310 |
Why?
|
| Stress, Psychological | 12 | 2017 | 4538 | 0.310 |
Why?
|
| Alphapapillomavirus | 2 | 2022 | 218 | 0.310 |
Why?
|
| Polymorphism, Single Nucleotide | 23 | 2022 | 16023 | 0.310 |
Why?
|
| Principal Component Analysis | 3 | 2023 | 949 | 0.310 |
Why?
|
| Community-Institutional Relations | 4 | 2016 | 208 | 0.300 |
Why?
|
| Anesthesia, Conduction | 1 | 2011 | 263 | 0.300 |
Why?
|
| Registries | 6 | 2019 | 8372 | 0.300 |
Why?
|
| Antineoplastic Agents, Hormonal | 5 | 2022 | 1536 | 0.300 |
Why?
|
| Alcoholic Beverages | 8 | 2014 | 266 | 0.300 |
Why?
|
| Heart Valve Diseases | 1 | 2016 | 1033 | 0.300 |
Why?
|
| Fractures, Bone | 8 | 1998 | 2063 | 0.300 |
Why?
|
| Vitamin B Complex | 2 | 2009 | 299 | 0.300 |
Why?
|
| Social Desirability | 1 | 2008 | 46 | 0.300 |
Why?
|
| Psychometrics | 7 | 2017 | 3072 | 0.300 |
Why?
|
| Femoracetabular Impingement | 2 | 2022 | 180 | 0.300 |
Why?
|
| Chemotherapy, Adjuvant | 6 | 2022 | 3550 | 0.290 |
Why?
|
| Aviation | 1 | 2007 | 49 | 0.290 |
Why?
|
| Linear Models | 18 | 2020 | 5880 | 0.290 |
Why?
|
| Vitamins | 11 | 2006 | 1638 | 0.290 |
Why?
|
| Telemedicine | 4 | 2023 | 3104 | 0.290 |
Why?
|
| Mitral Valve | 1 | 2016 | 1473 | 0.290 |
Why?
|
| Maternal Age | 13 | 2006 | 809 | 0.280 |
Why?
|
| Contraceptives, Oral, Hormonal | 7 | 2010 | 190 | 0.280 |
Why?
|
| Security Measures | 1 | 2007 | 83 | 0.280 |
Why?
|
| Nevus | 3 | 2005 | 206 | 0.280 |
Why?
|
| Retrospective Studies | 45 | 2023 | 81835 | 0.280 |
Why?
|
| Workplace | 5 | 2019 | 872 | 0.280 |
Why?
|
| Cathartics | 7 | 2013 | 129 | 0.280 |
Why?
|
| Micronutrients | 4 | 2014 | 390 | 0.280 |
Why?
|
| Negative-Pressure Wound Therapy | 2 | 2020 | 156 | 0.280 |
Why?
|
| Thinness | 3 | 2008 | 483 | 0.280 |
Why?
|
| Employment | 4 | 2018 | 1120 | 0.280 |
Why?
|
| Teaching | 3 | 2011 | 1174 | 0.280 |
Why?
|
| Prostatic Hyperplasia | 6 | 2021 | 523 | 0.270 |
Why?
|
| Physical Fitness | 7 | 2013 | 744 | 0.270 |
Why?
|
| Stem Cell Transplantation | 1 | 2015 | 1602 | 0.270 |
Why?
|
| Lymphoma, Non-Hodgkin | 6 | 2022 | 1376 | 0.270 |
Why?
|
| Population Dynamics | 1 | 2008 | 314 | 0.270 |
Why?
|
| Science | 1 | 2009 | 239 | 0.270 |
Why?
|
| Program Evaluation | 11 | 2020 | 2508 | 0.270 |
Why?
|
| BRCA2 Protein | 2 | 2023 | 802 | 0.270 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 2007 | 126 | 0.270 |
Why?
|
| Infant, Newborn | 21 | 2021 | 26394 | 0.260 |
Why?
|
| Universities | 3 | 2016 | 1007 | 0.260 |
Why?
|
| Pulmonary Embolism | 5 | 2017 | 2591 | 0.260 |
Why?
|
| Nicotine | 4 | 2012 | 681 | 0.260 |
Why?
|
| Cataract Extraction | 10 | 2004 | 465 | 0.260 |
Why?
|
| Disease Progression | 11 | 2024 | 13643 | 0.260 |
Why?
|
| Forecasting | 10 | 2020 | 2950 | 0.260 |
Why?
|
| Cataract | 10 | 2002 | 837 | 0.260 |
Why?
|
| Marital Status | 4 | 2004 | 426 | 0.260 |
Why?
|
| Pneumonectomy | 5 | 2016 | 1159 | 0.260 |
Why?
|
| Evidence-Based Practice | 4 | 2016 | 500 | 0.260 |
Why?
|
| Nutrition Policy | 4 | 2004 | 467 | 0.260 |
Why?
|
| Haplotypes | 15 | 2010 | 2723 | 0.260 |
Why?
|
| Gene Expression Regulation, Neoplastic | 8 | 2024 | 8636 | 0.250 |
Why?
|
| Education, Medical, Graduate | 4 | 2013 | 2411 | 0.250 |
Why?
|
| Recreation | 4 | 2008 | 125 | 0.250 |
Why?
|
| Occult Blood | 4 | 2021 | 199 | 0.250 |
Why?
|
| Colonic Polyps | 9 | 2013 | 557 | 0.250 |
Why?
|
| Somatotypes | 1 | 2005 | 41 | 0.250 |
Why?
|
| Health Expenditures | 7 | 2023 | 2391 | 0.250 |
Why?
|
| Family Practice | 10 | 1982 | 510 | 0.250 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 1 | 2006 | 161 | 0.250 |
Why?
|
| Macular Degeneration | 3 | 2008 | 1016 | 0.250 |
Why?
|
| Antioxidants | 10 | 2013 | 1678 | 0.250 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2016 | 1569 | 0.250 |
Why?
|
| Quality Improvement | 3 | 2019 | 3858 | 0.250 |
Why?
|
| Sex Distribution | 9 | 2015 | 2286 | 0.250 |
Why?
|
| Interdisciplinary Studies | 2 | 2018 | 86 | 0.240 |
Why?
|
| Education, Medical | 3 | 2013 | 1742 | 0.240 |
Why?
|
| Genetic Variation | 9 | 2010 | 6607 | 0.240 |
Why?
|
| Walking | 7 | 2008 | 1202 | 0.240 |
Why?
|
| Cost-Benefit Analysis | 16 | 2019 | 5532 | 0.240 |
Why?
|
| Heart-Assist Devices | 1 | 2015 | 1292 | 0.240 |
Why?
|
| Child Day Care Centers | 1 | 2005 | 122 | 0.240 |
Why?
|
| Myocardial Infarction | 21 | 2017 | 11515 | 0.240 |
Why?
|
| Digestive System Surgical Procedures | 2 | 2021 | 584 | 0.240 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 7 | 2010 | 415 | 0.230 |
Why?
|
| Orthopedic Procedures | 3 | 2021 | 1280 | 0.230 |
Why?
|
| Tobacco Use Disorder | 2 | 2020 | 710 | 0.230 |
Why?
|
| Vasectomy | 4 | 1994 | 52 | 0.230 |
Why?
|
| Statistics, Nonparametric | 5 | 2024 | 2861 | 0.230 |
Why?
|
| Age of Onset | 10 | 2020 | 3342 | 0.230 |
Why?
|
| Social Adjustment | 1 | 2007 | 635 | 0.230 |
Why?
|
| Aromatase Inhibitors | 3 | 2019 | 518 | 0.230 |
Why?
|
| Thrombophlebitis | 5 | 1996 | 289 | 0.230 |
Why?
|
| Progesterone | 3 | 2018 | 749 | 0.230 |
Why?
|
| Receptor, erbB-2 | 10 | 2024 | 2586 | 0.230 |
Why?
|
| Vitamin D Deficiency | 1 | 2014 | 1389 | 0.230 |
Why?
|
| Statistics as Topic | 10 | 2014 | 2362 | 0.230 |
Why?
|
| Ethanol | 6 | 2015 | 1334 | 0.230 |
Why?
|
| Critical Illness | 1 | 2017 | 2754 | 0.230 |
Why?
|
| Reproduction | 7 | 2013 | 646 | 0.230 |
Why?
|
| Residence Characteristics | 11 | 2020 | 2119 | 0.220 |
Why?
|
| Chewing Gum | 3 | 1996 | 40 | 0.220 |
Why?
|
| Publication Bias | 3 | 2004 | 160 | 0.220 |
Why?
|
| Mammary Glands, Human | 2 | 2015 | 202 | 0.220 |
Why?
|
| Dietary Services | 1 | 2003 | 17 | 0.220 |
Why?
|
| Occupational Diseases | 4 | 2002 | 1494 | 0.220 |
Why?
|
| Testosterone | 8 | 2018 | 2493 | 0.220 |
Why?
|
| Esophageal Neoplasms | 2 | 2023 | 1676 | 0.220 |
Why?
|
| Australia | 19 | 2017 | 1264 | 0.220 |
Why?
|
| Intensive Care Units | 1 | 2017 | 3804 | 0.220 |
Why?
|
| Melatonin | 3 | 2004 | 669 | 0.220 |
Why?
|
| Radius Fractures | 3 | 1998 | 514 | 0.220 |
Why?
|
| Public Assistance | 1 | 2003 | 47 | 0.220 |
Why?
|
| Probability | 12 | 2007 | 2483 | 0.220 |
Why?
|
| Dietary Sucrose | 5 | 2005 | 243 | 0.220 |
Why?
|
| Exercise Therapy | 3 | 2021 | 941 | 0.210 |
Why?
|
| Guatemala | 2 | 2013 | 161 | 0.210 |
Why?
|
| Consumer Health Information | 2 | 2016 | 215 | 0.210 |
Why?
|
| Carcinoma, Basal Cell | 11 | 2008 | 564 | 0.210 |
Why?
|
| Rural Population | 7 | 2020 | 2317 | 0.210 |
Why?
|
| Urban Population | 8 | 2020 | 2047 | 0.210 |
Why?
|
| Pectoralis Muscles | 1 | 2023 | 86 | 0.210 |
Why?
|
| Nails | 5 | 1998 | 298 | 0.210 |
Why?
|
| Bone Density | 6 | 2015 | 3561 | 0.210 |
Why?
|
| Sepsis | 1 | 2017 | 2602 | 0.210 |
Why?
|
| Milk, Human | 2 | 2005 | 489 | 0.210 |
Why?
|
| Fatty Acids, Essential | 2 | 2000 | 97 | 0.210 |
Why?
|
| Tuberculosis | 7 | 2001 | 2029 | 0.210 |
Why?
|
| Guideline Adherence | 4 | 2016 | 2239 | 0.210 |
Why?
|
| Vital Capacity | 2 | 2005 | 984 | 0.210 |
Why?
|
| Anabolic Agents | 1 | 2005 | 256 | 0.210 |
Why?
|
| Models, Theoretical | 8 | 2020 | 3590 | 0.210 |
Why?
|
| Intensive Care, Neonatal | 2 | 2021 | 200 | 0.210 |
Why?
|
| Causality | 6 | 2018 | 1255 | 0.200 |
Why?
|
| Self Care | 3 | 2020 | 798 | 0.200 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2005 | 395 | 0.200 |
Why?
|
| Heart Diseases | 8 | 2022 | 2816 | 0.200 |
Why?
|
| Selenium | 6 | 1996 | 419 | 0.200 |
Why?
|
| Hair Dyes | 4 | 1996 | 30 | 0.200 |
Why?
|
| Cyclic AMP Response Element-Binding Protein A | 1 | 2021 | 21 | 0.190 |
Why?
|
| Educational Status | 8 | 2023 | 2519 | 0.190 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2011 | 2040 | 0.190 |
Why?
|
| Fetal Hypoxia | 1 | 2021 | 30 | 0.190 |
Why?
|
| North Dakota | 3 | 2006 | 14 | 0.190 |
Why?
|
| Nocturia | 1 | 2021 | 18 | 0.190 |
Why?
|
| Suicide | 5 | 2004 | 1608 | 0.190 |
Why?
|
| Patient Care Team | 2 | 2015 | 2526 | 0.190 |
Why?
|
| Receptors, Calcitriol | 2 | 2006 | 361 | 0.190 |
Why?
|
| Qualitative Research | 5 | 2024 | 3115 | 0.190 |
Why?
|
| Infertility, Female | 5 | 2019 | 764 | 0.190 |
Why?
|
| Patient Protection and Affordable Care Act | 3 | 2020 | 1189 | 0.190 |
Why?
|
| Nutritional Requirements | 3 | 2018 | 279 | 0.180 |
Why?
|
| Continuity of Patient Care | 3 | 2021 | 1076 | 0.180 |
Why?
|
| Digestive System Neoplasms | 1 | 2021 | 83 | 0.180 |
Why?
|
| Estradiol | 12 | 2019 | 1948 | 0.180 |
Why?
|
| Pregnant Women | 1 | 2005 | 576 | 0.180 |
Why?
|
| Pollen | 1 | 2020 | 81 | 0.180 |
Why?
|
| Patient Compliance | 8 | 2013 | 2696 | 0.180 |
Why?
|
| Meteorological Concepts | 1 | 2020 | 30 | 0.180 |
Why?
|
| Boston | 12 | 2013 | 9359 | 0.180 |
Why?
|
| Curriculum | 9 | 2021 | 3778 | 0.180 |
Why?
|
| Dose-Response Relationship, Drug | 16 | 2012 | 10784 | 0.180 |
Why?
|
| Public Health Administration | 3 | 2012 | 242 | 0.180 |
Why?
|
| Forced Expiratory Volume | 2 | 2005 | 1820 | 0.180 |
Why?
|
| Massachusetts | 16 | 2018 | 8905 | 0.180 |
Why?
|
| Delivery of Health Care | 6 | 2022 | 5367 | 0.180 |
Why?
|
| Perception | 2 | 2017 | 1207 | 0.170 |
Why?
|
| Ulna Fractures | 2 | 1998 | 126 | 0.170 |
Why?
|
| Infant | 12 | 2022 | 36496 | 0.170 |
Why?
|
| Guidelines as Topic | 6 | 2012 | 1395 | 0.170 |
Why?
|
| Fatty Acids | 7 | 2016 | 1818 | 0.170 |
Why?
|
| Alcoholism | 4 | 2007 | 1993 | 0.170 |
Why?
|
| Remote Consultation | 1 | 2023 | 242 | 0.170 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2002 | 219 | 0.170 |
Why?
|
| Tobacco Industry | 2 | 2007 | 138 | 0.170 |
Why?
|
| Oligohydramnios | 1 | 2019 | 37 | 0.170 |
Why?
|
| Education, Medical, Undergraduate | 7 | 1983 | 1081 | 0.170 |
Why?
|
| Parents | 5 | 2021 | 3596 | 0.170 |
Why?
|
| Life Change Events | 2 | 2022 | 964 | 0.170 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2011 | 3520 | 0.170 |
Why?
|
| Alleles | 15 | 2016 | 6880 | 0.170 |
Why?
|
| Myeloma Proteins | 1 | 2019 | 71 | 0.170 |
Why?
|
| Kidney Neoplasms | 1 | 2016 | 4299 | 0.170 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2023 | 277 | 0.170 |
Why?
|
| Sensitivity and Specificity | 17 | 2017 | 14725 | 0.170 |
Why?
|
| Genotype | 27 | 2013 | 13045 | 0.170 |
Why?
|
| Washington | 2 | 2020 | 314 | 0.170 |
Why?
|
| Synkinesis | 1 | 2019 | 23 | 0.170 |
Why?
|
| Physical Stimulation | 1 | 2021 | 517 | 0.170 |
Why?
|
| Cytogenetic Analysis | 1 | 2020 | 270 | 0.170 |
Why?
|
| Feeding and Eating Disorders of Childhood | 1 | 1999 | 42 | 0.160 |
Why?
|
| Models, Biological | 6 | 2018 | 9505 | 0.160 |
Why?
|
| Drug Therapy, Combination | 5 | 2016 | 6320 | 0.160 |
Why?
|
| Health Plan Implementation | 3 | 2018 | 338 | 0.160 |
Why?
|
| Tooth Loss | 4 | 2005 | 200 | 0.160 |
Why?
|
| Light | 2 | 2004 | 1357 | 0.160 |
Why?
|
| Algorithms | 8 | 2023 | 14157 | 0.160 |
Why?
|
| Data Collection | 8 | 2015 | 3329 | 0.160 |
Why?
|
| Papillomavirus Infections | 2 | 2022 | 1637 | 0.160 |
Why?
|
| Clomiphene | 1 | 2019 | 71 | 0.160 |
Why?
|
| Estrone | 7 | 2018 | 234 | 0.160 |
Why?
|
| Mathematical Computing | 3 | 2007 | 142 | 0.160 |
Why?
|
| Acidosis | 1 | 2021 | 271 | 0.160 |
Why?
|
| Nonprescription Drugs | 3 | 2008 | 119 | 0.160 |
Why?
|
| History, 21st Century | 3 | 2020 | 1575 | 0.160 |
Why?
|
| Prolactin | 6 | 2018 | 626 | 0.160 |
Why?
|
| Uterine Neoplasms | 3 | 2023 | 1423 | 0.160 |
Why?
|
| Colles' Fracture | 1 | 1998 | 11 | 0.160 |
Why?
|
| Glucose Tolerance Test | 3 | 2020 | 1181 | 0.160 |
Why?
|
| Pregnancy in Diabetics | 1 | 2020 | 198 | 0.160 |
Why?
|
| Osteoporosis | 5 | 2002 | 1606 | 0.160 |
Why?
|
| Dehydroepiandrosterone Sulfate | 4 | 2014 | 241 | 0.160 |
Why?
|
| Fertility Agents, Female | 1 | 2019 | 101 | 0.160 |
Why?
|
| Predictive Value of Tests | 14 | 2017 | 15459 | 0.160 |
Why?
|
| Fluoridation | 1 | 1998 | 29 | 0.160 |
Why?
|
| Bandages | 1 | 2020 | 273 | 0.160 |
Why?
|
| Disease-Free Survival | 6 | 2024 | 6856 | 0.160 |
Why?
|
| Patient Readmission | 4 | 2021 | 3308 | 0.150 |
Why?
|
| Adiponectin | 3 | 2017 | 1118 | 0.150 |
Why?
|
| Diffusion of Innovation | 3 | 2017 | 730 | 0.150 |
Why?
|
| Genetic Loci | 4 | 2020 | 2630 | 0.150 |
Why?
|
| Physicians, Women | 1 | 2004 | 519 | 0.150 |
Why?
|
| Speech Acoustics | 1 | 2019 | 155 | 0.150 |
Why?
|
| Women's Health Services | 1 | 1999 | 88 | 0.150 |
Why?
|
| Inflammation Mediators | 2 | 2018 | 1892 | 0.150 |
Why?
|
| Premature Birth | 3 | 2016 | 1816 | 0.150 |
Why?
|
| Education, Medical, Continuing | 7 | 2021 | 829 | 0.150 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 2 | 2005 | 78 | 0.150 |
Why?
|
| High-Frequency Ventilation | 1 | 1998 | 90 | 0.150 |
Why?
|
| Problem-Based Learning | 1 | 2002 | 356 | 0.150 |
Why?
|
| Dehydroepiandrosterone | 4 | 2005 | 259 | 0.150 |
Why?
|
| Women, Working | 1 | 1999 | 86 | 0.150 |
Why?
|
| Child, Preschool | 14 | 2022 | 42620 | 0.150 |
Why?
|
| Tuberculosis, Pulmonary | 2 | 1995 | 846 | 0.150 |
Why?
|
| Cognition | 5 | 2021 | 7062 | 0.150 |
Why?
|
| Gestational Age | 3 | 2021 | 3615 | 0.150 |
Why?
|
| Anesthetics, Dissociative | 1 | 2018 | 80 | 0.150 |
Why?
|
| Hip Joint | 2 | 2022 | 1018 | 0.150 |
Why?
|
| Anti-Infective Agents | 2 | 2019 | 986 | 0.150 |
Why?
|
| Fluorides | 1 | 1998 | 134 | 0.150 |
Why?
|
| Behavior | 2 | 1998 | 545 | 0.150 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2021 | 417 | 0.140 |
Why?
|
| Eggs | 3 | 2006 | 182 | 0.140 |
Why?
|
| Rectal Diseases | 1 | 2019 | 142 | 0.140 |
Why?
|
| Catechol O-Methyltransferase | 3 | 2004 | 251 | 0.140 |
Why?
|
| Sound | 1 | 2019 | 260 | 0.140 |
Why?
|
| Benzothiadiazines | 1 | 1997 | 31 | 0.140 |
Why?
|
| Multicenter Studies as Topic | 3 | 2010 | 1727 | 0.140 |
Why?
|
| Parent-Child Relations | 2 | 2007 | 775 | 0.140 |
Why?
|
| Colonic Diseases | 1 | 2019 | 203 | 0.140 |
Why?
|
| Health Communication | 1 | 2020 | 216 | 0.140 |
Why?
|
| Disease Susceptibility | 4 | 2019 | 1796 | 0.140 |
Why?
|
| Lymphatic Metastasis | 8 | 2019 | 2930 | 0.140 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2017 | 103 | 0.140 |
Why?
|
| Integrin beta3 | 1 | 2017 | 120 | 0.140 |
Why?
|
| MEDLINE | 4 | 2005 | 119 | 0.140 |
Why?
|
| Appointments and Schedules | 1 | 2021 | 443 | 0.140 |
Why?
|
| Urinary Incontinence | 2 | 2021 | 494 | 0.140 |
Why?
|
| Steroids | 3 | 2016 | 937 | 0.140 |
Why?
|
| Urologic Diseases | 1 | 2019 | 247 | 0.140 |
Why?
|
| Income | 2 | 2023 | 1878 | 0.140 |
Why?
|
| Femoral Neck Fractures | 1 | 1998 | 143 | 0.140 |
Why?
|
| Resistin | 1 | 2017 | 172 | 0.140 |
Why?
|
| Sexual Maturation | 1 | 2018 | 261 | 0.140 |
Why?
|
| Pelvic Inflammatory Disease | 1 | 2017 | 96 | 0.140 |
Why?
|
| Subcutaneous Fat | 1 | 2020 | 402 | 0.140 |
Why?
|
| Betaine | 2 | 2007 | 90 | 0.140 |
Why?
|
| Accidents | 3 | 1996 | 165 | 0.140 |
Why?
|
| Medication Adherence | 2 | 2022 | 2190 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 7 | 2020 | 20763 | 0.140 |
Why?
|
| Attitude of Health Personnel | 10 | 2023 | 3922 | 0.140 |
Why?
|
| Insurance, Health | 2 | 2019 | 2513 | 0.140 |
Why?
|
| beta Carotene | 7 | 2003 | 523 | 0.130 |
Why?
|
| Polymethacrylic Acids | 1 | 1996 | 32 | 0.130 |
Why?
|
| Transportation | 1 | 2018 | 218 | 0.130 |
Why?
|
| Informed Consent | 1 | 2023 | 1012 | 0.130 |
Why?
|
| Private Sector | 1 | 2019 | 395 | 0.130 |
Why?
|
| BRCA1 Protein | 1 | 2023 | 1158 | 0.130 |
Why?
|
| Muscle, Skeletal | 3 | 2020 | 4984 | 0.130 |
Why?
|
| Antisepsis | 1 | 2016 | 16 | 0.130 |
Why?
|
| History, 20th Century | 3 | 2016 | 2772 | 0.130 |
Why?
|
| Labor, Obstetric | 1 | 2019 | 323 | 0.130 |
Why?
|
| Diet, Mediterranean | 1 | 2023 | 747 | 0.130 |
Why?
|
| Vitamin K | 1 | 1999 | 314 | 0.130 |
Why?
|
| Energy Metabolism | 10 | 2013 | 2901 | 0.130 |
Why?
|
| Libraries | 1 | 2016 | 21 | 0.130 |
Why?
|
| Fatty Acids, Omega-3 | 4 | 2014 | 1398 | 0.130 |
Why?
|
| Genetic Testing | 2 | 2019 | 3586 | 0.130 |
Why?
|
| Beauty Culture | 3 | 2006 | 41 | 0.130 |
Why?
|
| Libraries, Medical | 1 | 2016 | 12 | 0.130 |
Why?
|
| Combined Modality Therapy | 7 | 2019 | 8559 | 0.130 |
Why?
|
| Sterilization, Tubal | 5 | 2007 | 78 | 0.130 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2022 | 1036 | 0.130 |
Why?
|
| Receptors, Androgen | 3 | 2011 | 1084 | 0.130 |
Why?
|
| Methionine | 6 | 2002 | 574 | 0.130 |
Why?
|
| Narration | 2 | 2020 | 221 | 0.130 |
Why?
|
| Paternal Age | 3 | 2006 | 87 | 0.130 |
Why?
|
| Cholesterol | 10 | 2006 | 2910 | 0.130 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2017 | 227 | 0.130 |
Why?
|
| Physicians | 4 | 2020 | 4615 | 0.130 |
Why?
|
| Genome-Wide Association Study | 9 | 2022 | 12771 | 0.130 |
Why?
|
| Muscular Diseases | 1 | 2020 | 555 | 0.130 |
Why?
|
| Child Behavior | 2 | 2008 | 862 | 0.120 |
Why?
|
| Facial Paralysis | 1 | 2019 | 346 | 0.120 |
Why?
|
| Accidental Falls | 2 | 2016 | 1081 | 0.120 |
Why?
|
| Polyvinyls | 1 | 1996 | 156 | 0.120 |
Why?
|
| Wrist Injuries | 1 | 1998 | 215 | 0.120 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2019 | 350 | 0.120 |
Why?
|
| Training Support | 1 | 2015 | 109 | 0.120 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 1999 | 495 | 0.120 |
Why?
|
| Musculoskeletal Diseases | 2 | 2019 | 601 | 0.120 |
Why?
|
| Drug Approval | 2 | 2020 | 817 | 0.120 |
Why?
|
| Acetaldehyde | 1 | 2015 | 39 | 0.120 |
Why?
|
| Aging | 10 | 2008 | 8762 | 0.120 |
Why?
|
| Hand Strength | 1 | 2018 | 465 | 0.120 |
Why?
|
| Cyclooxygenase 2 | 2 | 2022 | 599 | 0.120 |
Why?
|
| Lupus Erythematosus, Systemic | 3 | 1997 | 2173 | 0.120 |
Why?
|
| Defecation | 3 | 2001 | 191 | 0.120 |
Why?
|
| Drug and Narcotic Control | 1 | 1996 | 146 | 0.120 |
Why?
|
| Interviews as Topic | 3 | 2023 | 2733 | 0.120 |
Why?
|
| Medroxyprogesterone Acetate | 3 | 2006 | 156 | 0.120 |
Why?
|
| Databases, Factual | 9 | 2024 | 8081 | 0.120 |
Why?
|
| Myeloablative Agonists | 1 | 2015 | 210 | 0.120 |
Why?
|
| Montana | 2 | 2011 | 11 | 0.120 |
Why?
|
| Sports | 1 | 2001 | 709 | 0.120 |
Why?
|
| Intra-Abdominal Fat | 1 | 2020 | 623 | 0.120 |
Why?
|
| Lymph Node Excision | 2 | 2018 | 1276 | 0.120 |
Why?
|
| Schools | 4 | 2014 | 1496 | 0.120 |
Why?
|
| Drug Utilization | 4 | 2007 | 1192 | 0.120 |
Why?
|
| End Stage Liver Disease | 1 | 2019 | 370 | 0.120 |
Why?
|
| Choline | 2 | 2007 | 518 | 0.120 |
Why?
|
| Sleep | 2 | 2023 | 4796 | 0.120 |
Why?
|
| Behavioral Risk Factor Surveillance System | 2 | 2013 | 211 | 0.120 |
Why?
|
| Motivation | 6 | 2023 | 2034 | 0.120 |
Why?
|
| Chlorhexidine | 1 | 2016 | 160 | 0.120 |
Why?
|
| Focus Groups | 5 | 2024 | 1448 | 0.120 |
Why?
|
| Codon | 3 | 2006 | 598 | 0.120 |
Why?
|
| Carcinogens | 2 | 2009 | 455 | 0.120 |
Why?
|
| Students, Medical | 4 | 2002 | 1962 | 0.120 |
Why?
|
| Nutritional Status | 4 | 2015 | 1623 | 0.120 |
Why?
|
| Adenomatous Polyps | 3 | 2002 | 109 | 0.120 |
Why?
|
| Mexican Americans | 1 | 2015 | 164 | 0.120 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2019 | 11844 | 0.120 |
Why?
|
| Visual Acuity | 3 | 2008 | 2714 | 0.120 |
Why?
|
| PubMed | 1 | 2015 | 130 | 0.120 |
Why?
|
| Genital Neoplasms, Female | 1 | 2019 | 539 | 0.120 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 1999 | 462 | 0.120 |
Why?
|
| Random Allocation | 10 | 1999 | 2399 | 0.120 |
Why?
|
| Insurance Claim Review | 1 | 2019 | 745 | 0.110 |
Why?
|
| Mycobacterium bovis | 1 | 1995 | 148 | 0.110 |
Why?
|
| Caregivers | 5 | 2004 | 2302 | 0.110 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2020 | 493 | 0.110 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2016 | 348 | 0.110 |
Why?
|
| Androgens | 5 | 2010 | 1285 | 0.110 |
Why?
|
| Stomach Neoplasms | 2 | 2016 | 1484 | 0.110 |
Why?
|
| Infant Formula | 1 | 2015 | 195 | 0.110 |
Why?
|
| Hepatectomy | 1 | 2018 | 588 | 0.110 |
Why?
|
| Financing, Organized | 1 | 2015 | 206 | 0.110 |
Why?
|
| Morphine | 1 | 2018 | 658 | 0.110 |
Why?
|
| Electrosurgery | 1 | 2014 | 53 | 0.110 |
Why?
|
| Cyclin D1 | 2 | 2006 | 454 | 0.110 |
Why?
|
| Lymph Nodes | 5 | 2018 | 3472 | 0.110 |
Why?
|
| Body Temperature | 1 | 2017 | 781 | 0.110 |
Why?
|
| Job Satisfaction | 1 | 1998 | 549 | 0.110 |
Why?
|
| Information Storage and Retrieval | 1 | 2019 | 823 | 0.110 |
Why?
|
| Delivery, Obstetric | 1 | 2021 | 953 | 0.110 |
Why?
|
| Writing | 1 | 2015 | 200 | 0.110 |
Why?
|
| Stillbirth | 1 | 2017 | 376 | 0.110 |
Why?
|
| Health Priorities | 1 | 1997 | 379 | 0.110 |
Why?
|
| Depression, Postpartum | 1 | 2018 | 355 | 0.110 |
Why?
|
| Gallbladder Diseases | 3 | 2003 | 139 | 0.110 |
Why?
|
| Government Programs | 1 | 2016 | 278 | 0.110 |
Why?
|
| Reference Values | 9 | 2006 | 4941 | 0.110 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2016 | 248 | 0.110 |
Why?
|
| Isoprostanes | 1 | 2013 | 21 | 0.110 |
Why?
|
| Iodine | 1 | 2016 | 287 | 0.110 |
Why?
|
| Glycemic Index | 3 | 2005 | 400 | 0.110 |
Why?
|
| Glucose Intolerance | 1 | 2017 | 579 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 7 | 2019 | 7449 | 0.110 |
Why?
|
| Chemoprevention | 2 | 2014 | 326 | 0.110 |
Why?
|
| Lung Transplantation | 1 | 2023 | 1310 | 0.110 |
Why?
|
| Head and Neck Neoplasms | 2 | 2024 | 2915 | 0.110 |
Why?
|
| Depression | 8 | 2020 | 8235 | 0.110 |
Why?
|
| Gastric Bypass | 1 | 2021 | 829 | 0.110 |
Why?
|
| Puberty | 2 | 2011 | 502 | 0.100 |
Why?
|
| Superoxide Dismutase | 2 | 2007 | 596 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2014 | 387 | 0.100 |
Why?
|
| Estrogen Receptor alpha | 1 | 2017 | 582 | 0.100 |
Why?
|
| Models, Educational | 1 | 2015 | 375 | 0.100 |
Why?
|
| Coitus | 2 | 2004 | 134 | 0.100 |
Why?
|
| Tumor Burden | 2 | 2016 | 1909 | 0.100 |
Why?
|
| Food Preferences | 4 | 2005 | 399 | 0.100 |
Why?
|
| Chromatin | 1 | 2024 | 2973 | 0.100 |
Why?
|
| Medical History Taking | 6 | 2022 | 776 | 0.100 |
Why?
|
| Access to Information | 1 | 2016 | 317 | 0.100 |
Why?
|
| Urban Renewal | 1 | 2012 | 9 | 0.100 |
Why?
|
| Health Care Surveys | 4 | 2013 | 2437 | 0.100 |
Why?
|
| Radon | 1 | 1994 | 91 | 0.100 |
Why?
|
| Animals | 22 | 2022 | 169424 | 0.100 |
Why?
|
| Proteinuria | 1 | 2015 | 613 | 0.100 |
Why?
|
| Community Health Services | 3 | 2013 | 659 | 0.100 |
Why?
|
| DNA-Binding Proteins | 7 | 2009 | 9623 | 0.100 |
Why?
|
| Ketamine | 1 | 2018 | 524 | 0.100 |
Why?
|
| Cholangiocarcinoma | 1 | 2018 | 563 | 0.100 |
Why?
|
| Morbidity | 5 | 2019 | 1760 | 0.100 |
Why?
|
| Circadian Rhythm | 2 | 2001 | 2585 | 0.100 |
Why?
|
| Menstrual Cycle | 4 | 2001 | 542 | 0.100 |
Why?
|
| Bile Duct Neoplasms | 1 | 2018 | 617 | 0.100 |
Why?
|
| Clinical Protocols | 3 | 2013 | 1444 | 0.100 |
Why?
|
| Thromboembolism | 2 | 2017 | 1005 | 0.100 |
Why?
|
| Pain Measurement | 2 | 2019 | 3577 | 0.100 |
Why?
|
| Local Government | 1 | 2012 | 83 | 0.100 |
Why?
|
| Health Planning Guidelines | 1 | 2012 | 151 | 0.100 |
Why?
|
| Dyspepsia | 2 | 1990 | 116 | 0.100 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 2 | 2003 | 246 | 0.100 |
Why?
|
| Population Density | 1 | 2012 | 193 | 0.100 |
Why?
|
| Calcium | 5 | 2012 | 5793 | 0.100 |
Why?
|
| Ontario | 2 | 2014 | 403 | 0.100 |
Why?
|
| Acne Vulgaris | 2 | 2008 | 351 | 0.100 |
Why?
|
| Technology Assessment, Biomedical | 2 | 1999 | 308 | 0.090 |
Why?
|
| Homocysteine | 2 | 2006 | 637 | 0.090 |
Why?
|
| Fatigue | 1 | 2018 | 1556 | 0.090 |
Why?
|
| Parkinson Disease | 5 | 2003 | 2892 | 0.090 |
Why?
|
| Interinstitutional Relations | 1 | 2012 | 236 | 0.090 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2011 | 2847 | 0.090 |
Why?
|
| Carcinogens, Environmental | 1 | 2011 | 72 | 0.090 |
Why?
|
| Anxiety | 4 | 2020 | 4655 | 0.090 |
Why?
|
| Doxorubicin | 2 | 2015 | 2229 | 0.090 |
Why?
|
| Heart Failure | 1 | 2015 | 11859 | 0.090 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2014 | 289 | 0.090 |
Why?
|
| Pleural Effusion, Malignant | 1 | 2012 | 108 | 0.090 |
Why?
|
| Poisson Distribution | 3 | 2022 | 509 | 0.090 |
Why?
|
| Molecular Typing | 1 | 2011 | 116 | 0.090 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2015 | 679 | 0.090 |
Why?
|
| Postoperative Care | 1 | 2017 | 1481 | 0.090 |
Why?
|
| Infant, Low Birth Weight | 4 | 2016 | 875 | 0.090 |
Why?
|
| Peer Review, Research | 2 | 2011 | 342 | 0.090 |
Why?
|
| Safety Management | 2 | 2007 | 764 | 0.090 |
Why?
|
| United States Department of Agriculture | 2 | 2004 | 47 | 0.090 |
Why?
|
| Abdomen | 4 | 2005 | 1136 | 0.090 |
Why?
|
| Breast Implants | 3 | 2001 | 414 | 0.090 |
Why?
|
| Physician-Patient Relations | 4 | 2024 | 3267 | 0.090 |
Why?
|
| Cold Climate | 1 | 1990 | 7 | 0.090 |
Why?
|
| Bone Resorption | 1 | 2014 | 727 | 0.090 |
Why?
|
| Illinois | 2 | 2020 | 120 | 0.090 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2014 | 387 | 0.090 |
Why?
|
| Hypercholesterolemia | 7 | 2002 | 1142 | 0.090 |
Why?
|
| National Health Programs | 1 | 2013 | 442 | 0.090 |
Why?
|
| Midwestern United States | 2 | 2022 | 70 | 0.090 |
Why?
|
| Ovary | 4 | 2011 | 960 | 0.090 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 2 | 2001 | 99 | 0.090 |
Why?
|
| Blood Glucose | 8 | 2005 | 6429 | 0.090 |
Why?
|
| Tuberculin Test | 3 | 1995 | 205 | 0.090 |
Why?
|
| Restaurants | 1 | 2012 | 232 | 0.080 |
Why?
|
| Europe | 8 | 2014 | 3439 | 0.080 |
Why?
|
| Physician's Role | 1 | 2016 | 927 | 0.080 |
Why?
|
| Laparoscopy | 1 | 2021 | 2056 | 0.080 |
Why?
|
| Venous Thromboembolism | 1 | 2023 | 1881 | 0.080 |
Why?
|
| Fellowships and Scholarships | 2 | 2015 | 1134 | 0.080 |
Why?
|
| Mastectomy | 2 | 2016 | 1852 | 0.080 |
Why?
|
| Blood Pressure | 7 | 2012 | 8537 | 0.080 |
Why?
|
| Gene Expression | 4 | 2022 | 7605 | 0.080 |
Why?
|
| Checklist | 1 | 2016 | 843 | 0.080 |
Why?
|
| Estrogen Receptor beta | 2 | 2008 | 171 | 0.080 |
Why?
|
| Pain, Postoperative | 1 | 2020 | 1763 | 0.080 |
Why?
|
| Maternal Exposure | 1 | 2017 | 1078 | 0.080 |
Why?
|
| Diphosphonates | 1 | 2014 | 635 | 0.080 |
Why?
|
| Diabetic Angiopathies | 3 | 2002 | 806 | 0.080 |
Why?
|
| Pregnancy Outcome | 2 | 2019 | 2959 | 0.080 |
Why?
|
| Antacids | 1 | 1989 | 94 | 0.080 |
Why?
|
| Hematologic Diseases | 1 | 2013 | 499 | 0.080 |
Why?
|
| Ultraviolet Rays | 2 | 2006 | 1100 | 0.080 |
Why?
|
| Trust | 2 | 2011 | 532 | 0.080 |
Why?
|
| Telomerase | 1 | 2014 | 749 | 0.080 |
Why?
|
| Carbonated Beverages | 3 | 2005 | 210 | 0.080 |
Why?
|
| Cross-Over Studies | 3 | 2020 | 2103 | 0.080 |
Why?
|
| Industry | 1 | 2011 | 366 | 0.080 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2017 | 3619 | 0.080 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2018 | 5708 | 0.080 |
Why?
|
| Tissue Array Analysis | 4 | 2011 | 551 | 0.080 |
Why?
|
| Absorptiometry, Photon | 1 | 2015 | 1749 | 0.080 |
Why?
|
| Transplantation Conditioning | 1 | 2015 | 1598 | 0.080 |
Why?
|
| State Medicine | 3 | 2006 | 217 | 0.080 |
Why?
|
| Carcinoma, Squamous Cell | 8 | 2008 | 4083 | 0.080 |
Why?
|
| Abortion, Spontaneous | 2 | 2019 | 539 | 0.080 |
Why?
|
| Electronic Health Records | 4 | 2023 | 4877 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2009 | 286 | 0.080 |
Why?
|
| Sex Hormone-Binding Globulin | 4 | 2014 | 554 | 0.080 |
Why?
|
| Amphetamines | 1 | 1989 | 144 | 0.080 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2011 | 384 | 0.080 |
Why?
|
| Health Services Needs and Demand | 1 | 2016 | 1408 | 0.080 |
Why?
|
| Hyperlipidemias | 2 | 2020 | 773 | 0.080 |
Why?
|
| Imidazoles | 1 | 2014 | 1174 | 0.080 |
Why?
|
| Urban Health | 2 | 2022 | 535 | 0.080 |
Why?
|
| Arylamine N-Acetyltransferase | 2 | 1999 | 87 | 0.070 |
Why?
|
| Snoring | 2 | 2000 | 209 | 0.070 |
Why?
|
| Selection Bias | 2 | 2008 | 360 | 0.070 |
Why?
|
| Gastroenterology | 1 | 2014 | 588 | 0.070 |
Why?
|
| Labetalol | 1 | 1987 | 29 | 0.070 |
Why?
|
| Syndrome | 3 | 2020 | 3278 | 0.070 |
Why?
|
| Hospitalization | 3 | 2021 | 10845 | 0.070 |
Why?
|
| Cross Infection | 1 | 2017 | 1425 | 0.070 |
Why?
|
| Gene Expression Profiling | 5 | 2024 | 9508 | 0.070 |
Why?
|
| Comprehension | 2 | 2011 | 641 | 0.070 |
Why?
|
| Surgical Procedures, Operative | 3 | 2015 | 1937 | 0.070 |
Why?
|
| Linkage Disequilibrium | 7 | 2009 | 1998 | 0.070 |
Why?
|
| Models, Econometric | 2 | 2016 | 215 | 0.070 |
Why?
|
| Insecticides | 2 | 2001 | 200 | 0.070 |
Why?
|
| Phobic Disorders | 2 | 2004 | 441 | 0.070 |
Why?
|
| Bone Marrow Cells | 1 | 2015 | 2415 | 0.070 |
Why?
|
| Asthma | 2 | 2004 | 6274 | 0.070 |
Why?
|
| Reminder Systems | 1 | 2010 | 386 | 0.070 |
Why?
|
| Lymphoma | 2 | 2013 | 1907 | 0.070 |
Why?
|
| Brachytherapy | 1 | 2015 | 1227 | 0.070 |
Why?
|
| Pilot Projects | 6 | 2020 | 8730 | 0.070 |
Why?
|
| Polychlorinated Biphenyls | 2 | 2001 | 236 | 0.070 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2008 | 187 | 0.070 |
Why?
|
| Anticoagulants | 1 | 2023 | 4835 | 0.070 |
Why?
|
| Lung | 3 | 2023 | 10090 | 0.070 |
Why?
|
| Reading | 1 | 2011 | 543 | 0.070 |
Why?
|
| Neoplasm Proteins | 3 | 2015 | 3611 | 0.070 |
Why?
|
| Magnesium | 5 | 2002 | 816 | 0.070 |
Why?
|
| Nitroglycerin | 1 | 1988 | 332 | 0.070 |
Why?
|
| International Cooperation | 1 | 2013 | 1439 | 0.070 |
Why?
|
| Dietary Fats, Unsaturated | 2 | 1999 | 224 | 0.070 |
Why?
|
| Models, Organizational | 2 | 2008 | 546 | 0.070 |
Why?
|
| Hospital Mortality | 2 | 2021 | 5371 | 0.070 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 2 | 2006 | 276 | 0.070 |
Why?
|
| Metformin | 1 | 2015 | 914 | 0.070 |
Why?
|
| Bone Density Conservation Agents | 1 | 2014 | 797 | 0.070 |
Why?
|
| Heparin | 4 | 2023 | 1636 | 0.070 |
Why?
|
| Stroke | 7 | 2011 | 9790 | 0.070 |
Why?
|
| Kidney Failure, Chronic | 1 | 2019 | 2489 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2009 | 640 | 0.070 |
Why?
|
| Reactive Oxygen Species | 1 | 2015 | 2150 | 0.070 |
Why?
|
| Community Medicine | 2 | 1983 | 23 | 0.070 |
Why?
|
| Physicians, Family | 2 | 2019 | 349 | 0.070 |
Why?
|
| Receptor, Melanocortin, Type 1 | 1 | 2006 | 74 | 0.070 |
Why?
|
| Developing Countries | 2 | 2013 | 2901 | 0.070 |
Why?
|
| Secondary Prevention | 1 | 2013 | 1479 | 0.070 |
Why?
|
| Phenotype | 4 | 2022 | 16712 | 0.070 |
Why?
|
| Hair Color | 4 | 2006 | 131 | 0.070 |
Why?
|
| Infection Control | 1 | 2014 | 985 | 0.070 |
Why?
|
| Feasibility Studies | 4 | 2020 | 5308 | 0.070 |
Why?
|
| Vulnerable Populations | 1 | 2012 | 717 | 0.070 |
Why?
|
| Silicones | 2 | 1999 | 228 | 0.070 |
Why?
|
| Analysis of Variance | 8 | 2004 | 6242 | 0.070 |
Why?
|
| Pregnancy Complications | 2 | 2020 | 2969 | 0.070 |
Why?
|
| Death Certificates | 1 | 2007 | 175 | 0.070 |
Why?
|
| Nutritional Physiological Phenomena | 2 | 2005 | 361 | 0.070 |
Why?
|
| 17-Hydroxysteroid Dehydrogenases | 1 | 2006 | 58 | 0.070 |
Why?
|
| Angina Pectoris | 3 | 1990 | 960 | 0.070 |
Why?
|
| Antineoplastic Agents | 4 | 2015 | 13709 | 0.060 |
Why?
|
| Cell Division | 3 | 1998 | 4479 | 0.060 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 1996 | 6035 | 0.060 |
Why?
|
| Tomography, Emission-Computed | 1 | 1989 | 1123 | 0.060 |
Why?
|
| Dihydroxycholecalciferols | 1 | 2005 | 17 | 0.060 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2007 | 213 | 0.060 |
Why?
|
| Valerates | 1 | 2005 | 20 | 0.060 |
Why?
|
| Pre-Eclampsia | 1 | 2015 | 1257 | 0.060 |
Why?
|
| Pulpitis | 1 | 2006 | 29 | 0.060 |
Why?
|
| Propranolol | 1 | 1987 | 493 | 0.060 |
Why?
|
| Analgesics, Opioid | 2 | 2021 | 3837 | 0.060 |
Why?
|
| Early Diagnosis | 2 | 2013 | 1196 | 0.060 |
Why?
|
| Fatty Acids, Unsaturated | 3 | 2000 | 542 | 0.060 |
Why?
|
| Intestine, Large | 1 | 2005 | 69 | 0.060 |
Why?
|
| Communication | 4 | 2016 | 3910 | 0.060 |
Why?
|
| Patient Preference | 1 | 2013 | 948 | 0.060 |
Why?
|
| Family Planning Services | 1 | 2008 | 276 | 0.060 |
Why?
|
| Cancer Care Facilities | 1 | 2008 | 424 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2007 | 453 | 0.060 |
Why?
|
| Iodine Radioisotopes | 1 | 1989 | 1035 | 0.060 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2008 | 263 | 0.060 |
Why?
|
| Carcinoma, Small Cell | 1 | 2007 | 420 | 0.060 |
Why?
|
| Tocopherols | 1 | 2005 | 44 | 0.060 |
Why?
|
| Psychological Tests | 1 | 2007 | 643 | 0.060 |
Why?
|
| Epigenesis, Genetic | 2 | 2016 | 3832 | 0.060 |
Why?
|
| Stromal Cells | 3 | 2022 | 1335 | 0.060 |
Why?
|
| Nursing | 1 | 2004 | 35 | 0.060 |
Why?
|
| Bone Neoplasms | 1 | 2017 | 2562 | 0.060 |
Why?
|
| Terrorism | 1 | 2007 | 211 | 0.060 |
Why?
|
| Physicians' Offices | 1 | 2005 | 60 | 0.060 |
Why?
|
| Hair | 2 | 2006 | 508 | 0.060 |
Why?
|
| Parenting | 2 | 2008 | 707 | 0.060 |
Why?
|
| Teaching Materials | 1 | 2005 | 85 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2016 | 4362 | 0.060 |
Why?
|
| North America | 5 | 2006 | 1292 | 0.060 |
Why?
|
| Play and Playthings | 1 | 2005 | 86 | 0.060 |
Why?
|
| Food, Organic | 1 | 2004 | 34 | 0.060 |
Why?
|
| Pigmentation | 1 | 2005 | 143 | 0.060 |
Why?
|
| Bone and Bones | 1 | 2015 | 2589 | 0.060 |
Why?
|
| California | 4 | 2013 | 1444 | 0.060 |
Why?
|
| Fishes | 3 | 2003 | 605 | 0.060 |
Why?
|
| Estrogen Antagonists | 1 | 2005 | 150 | 0.060 |
Why?
|
| Acculturation | 1 | 2006 | 179 | 0.060 |
Why?
|
| Lactose | 1 | 2004 | 95 | 0.060 |
Why?
|
| Hydroxysteroid Dehydrogenases | 1 | 2004 | 30 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2019 | 6537 | 0.060 |
Why?
|
| Social Control, Formal | 1 | 2004 | 107 | 0.060 |
Why?
|
| Drug Therapy | 1 | 2007 | 504 | 0.060 |
Why?
|
| C-Reactive Protein | 1 | 2016 | 3854 | 0.060 |
Why?
|
| Incubators | 1 | 2023 | 5 | 0.060 |
Why?
|
| Widowhood | 1 | 2004 | 51 | 0.060 |
Why?
|
| Genome, Human | 4 | 2016 | 4454 | 0.060 |
Why?
|
| Divorce | 1 | 2004 | 78 | 0.060 |
Why?
|
| Social Perception | 1 | 2008 | 434 | 0.060 |
Why?
|
| Central Nervous System Stimulants | 2 | 2011 | 1180 | 0.060 |
Why?
|
| Kidney Transplantation | 1 | 2019 | 4285 | 0.060 |
Why?
|
| Genetics, Medical | 1 | 2007 | 334 | 0.060 |
Why?
|
| Pandemics | 2 | 2022 | 8751 | 0.060 |
Why?
|
| Penetrance | 1 | 2005 | 384 | 0.060 |
Why?
|
| Nutritive Value | 2 | 2004 | 349 | 0.060 |
Why?
|
| Arthroscopy | 2 | 2022 | 971 | 0.060 |
Why?
|
| Genes, Neoplasm | 1 | 2005 | 371 | 0.060 |
Why?
|
| Clothing | 3 | 1991 | 96 | 0.060 |
Why?
|
| Ovulation | 2 | 2002 | 181 | 0.060 |
Why?
|
| Lumbar Vertebrae | 2 | 2006 | 1885 | 0.060 |
Why?
|
| Cholesterol, Dietary | 4 | 2001 | 224 | 0.050 |
Why?
|
| Cocarcinogenesis | 2 | 2004 | 49 | 0.050 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 2002 | 781 | 0.050 |
Why?
|
| Butter | 1 | 2003 | 22 | 0.050 |
Why?
|
| Diabetes Complications | 5 | 2002 | 1322 | 0.050 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2004 | 767 | 0.050 |
Why?
|
| Running | 1 | 2008 | 490 | 0.050 |
Why?
|
| Geography | 2 | 2016 | 654 | 0.050 |
Why?
|
| Periodontal Diseases | 2 | 2004 | 455 | 0.050 |
Why?
|
| Reoperation | 1 | 2014 | 4342 | 0.050 |
Why?
|
| Glucuronosyltransferase | 1 | 2004 | 136 | 0.050 |
Why?
|
| Safe Sex | 1 | 2004 | 144 | 0.050 |
Why?
|
| Graft vs Host Disease | 1 | 2016 | 3042 | 0.050 |
Why?
|
| Amino Acid Substitution | 2 | 2004 | 1742 | 0.050 |
Why?
|
| Fats | 1 | 2003 | 99 | 0.050 |
Why?
|
| Congresses as Topic | 2 | 2018 | 810 | 0.050 |
Why?
|
| Leiomyoma | 2 | 1998 | 641 | 0.050 |
Why?
|
| Inflammation | 2 | 2018 | 10863 | 0.050 |
Why?
|
| Minisatellite Repeats | 1 | 2003 | 164 | 0.050 |
Why?
|
| Publications | 1 | 2005 | 196 | 0.050 |
Why?
|
| Safety | 1 | 2007 | 1159 | 0.050 |
Why?
|
| Oxidative Stress | 4 | 2013 | 3145 | 0.050 |
Why?
|
| User-Computer Interface | 2 | 2020 | 1398 | 0.050 |
Why?
|
| DNA Damage | 2 | 2004 | 2461 | 0.050 |
Why?
|
| Tandem Repeat Sequences | 1 | 2003 | 182 | 0.050 |
Why?
|
| Intestinal Neoplasms | 1 | 2005 | 317 | 0.050 |
Why?
|
| Emigration and Immigration | 1 | 2006 | 405 | 0.050 |
Why?
|
| Caspases | 1 | 2006 | 884 | 0.050 |
Why?
|
| Cattle | 3 | 2022 | 3830 | 0.050 |
Why?
|
| Infant, Newborn, Diseases | 1 | 1988 | 592 | 0.050 |
Why?
|
| Dental Caries Susceptibility | 1 | 2022 | 28 | 0.050 |
Why?
|
| Progesterone Congeners | 1 | 2002 | 44 | 0.050 |
Why?
|
| Child Care | 1 | 2003 | 126 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3116 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
| Mental Health | 3 | 2020 | 3271 | 0.050 |
Why?
|
| Costs and Cost Analysis | 5 | 2013 | 1670 | 0.050 |
Why?
|
| Taxes | 1 | 2004 | 222 | 0.050 |
Why?
|
| Cooking | 3 | 1999 | 311 | 0.050 |
Why?
|
| China | 1 | 2008 | 2397 | 0.050 |
Why?
|
| Codon, Terminator | 1 | 2002 | 125 | 0.050 |
Why?
|
| Sexuality | 1 | 2004 | 180 | 0.050 |
Why?
|
| Embryonic and Fetal Development | 1 | 2003 | 420 | 0.050 |
Why?
|
| Secretory Rate | 1 | 2001 | 81 | 0.050 |
Why?
|
| Home Nursing | 1 | 2002 | 92 | 0.050 |
Why?
|
| Neoplasm Metastasis | 3 | 2020 | 4931 | 0.050 |
Why?
|
| Cultural Diversity | 1 | 2006 | 373 | 0.050 |
Why?
|
| Medical Records | 5 | 2013 | 1413 | 0.050 |
Why?
|
| Enoxaparin | 2 | 1995 | 391 | 0.050 |
Why?
|
| Achievement | 1 | 2003 | 288 | 0.050 |
Why?
|
| Family Characteristics | 3 | 2016 | 1001 | 0.050 |
Why?
|
| Potassium | 2 | 1999 | 1319 | 0.050 |
Why?
|
| Oligomenorrhea | 1 | 2001 | 42 | 0.050 |
Why?
|
| Politics | 3 | 2020 | 821 | 0.050 |
Why?
|
| Mutation | 4 | 2019 | 30235 | 0.050 |
Why?
|
| Spirometry | 1 | 2005 | 928 | 0.050 |
Why?
|
| Monoamine Oxidase | 1 | 2002 | 183 | 0.050 |
Why?
|
| B-Lymphocytes | 1 | 2015 | 4779 | 0.050 |
Why?
|
| Vitamin B 6 | 1 | 2003 | 234 | 0.050 |
Why?
|
| Mother-Child Relations | 1 | 2005 | 501 | 0.050 |
Why?
|
| PPAR gamma | 1 | 2004 | 487 | 0.050 |
Why?
|
| Single-Cell Analysis | 2 | 2024 | 2531 | 0.050 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2007 | 2768 | 0.050 |
Why?
|
| Drinking | 1 | 2002 | 198 | 0.050 |
Why?
|
| Colon | 2 | 2020 | 1804 | 0.050 |
Why?
|
| Siblings | 1 | 2006 | 829 | 0.050 |
Why?
|
| Pharmaceutical Preparations | 1 | 2010 | 1089 | 0.050 |
Why?
|
| Dichlorodiphenyl Dichloroethylene | 2 | 2001 | 86 | 0.050 |
Why?
|
| Osteoprotegerin | 1 | 2022 | 179 | 0.050 |
Why?
|
| Cross-Cultural Comparison | 1 | 2004 | 639 | 0.050 |
Why?
|
| Diet Fads | 1 | 2001 | 14 | 0.050 |
Why?
|
| Drug Administration Schedule | 4 | 2004 | 4861 | 0.050 |
Why?
|
| Silicone Gels | 1 | 2001 | 40 | 0.050 |
Why?
|
| Keratin-5 | 2 | 2011 | 45 | 0.050 |
Why?
|
| Microsatellite Repeats | 2 | 2000 | 784 | 0.050 |
Why?
|
| Diagnostic Tests, Routine | 2 | 2019 | 792 | 0.050 |
Why?
|
| Hospitals, Rural | 1 | 2023 | 176 | 0.050 |
Why?
|
| Abortion, Induced | 1 | 2007 | 475 | 0.050 |
Why?
|
| Vaccines | 1 | 2010 | 845 | 0.050 |
Why?
|
| Peer Review | 2 | 1980 | 217 | 0.050 |
Why?
|
| Hypolipidemic Agents | 1 | 2005 | 609 | 0.050 |
Why?
|
| Gene Frequency | 4 | 2014 | 3615 | 0.050 |
Why?
|
| Apgar Score | 1 | 2021 | 126 | 0.050 |
Why?
|
| Parkinson Disease, Secondary | 1 | 2001 | 122 | 0.050 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2023 | 344 | 0.050 |
Why?
|
| Genes, ras | 1 | 2003 | 666 | 0.050 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2007 | 3246 | 0.050 |
Why?
|
| Sigmoidoscopy | 5 | 2002 | 151 | 0.050 |
Why?
|
| Umbilical Arteries | 1 | 2021 | 77 | 0.050 |
Why?
|
| Computers | 1 | 2003 | 592 | 0.050 |
Why?
|
| Gastroesophageal Reflux | 1 | 2008 | 833 | 0.050 |
Why?
|
| DNA Repair | 3 | 2005 | 2051 | 0.050 |
Why?
|
| Public Policy | 1 | 1985 | 560 | 0.050 |
Why?
|
| Beer | 5 | 2004 | 135 | 0.050 |
Why?
|
| Remission Induction | 2 | 2015 | 2408 | 0.050 |
Why?
|
| Urination Disorders | 2 | 2019 | 238 | 0.040 |
Why?
|
| Plants, Toxic | 1 | 2000 | 70 | 0.040 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2003 | 462 | 0.040 |
Why?
|
| Pineal Gland | 1 | 2001 | 158 | 0.040 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2015 | 794 | 0.040 |
Why?
|
| Environment | 1 | 2007 | 1126 | 0.040 |
Why?
|
| Infertility | 1 | 2007 | 654 | 0.040 |
Why?
|
| Aldehyde Oxidoreductases | 1 | 2000 | 88 | 0.040 |
Why?
|
| Video Games | 1 | 2003 | 201 | 0.040 |
Why?
|
| Occupational Health Services | 1 | 2001 | 150 | 0.040 |
Why?
|
| Role | 1 | 2021 | 176 | 0.040 |
Why?
|
| Severity of Illness Index | 4 | 2013 | 15965 | 0.040 |
Why?
|
| Body Weight Changes | 1 | 1999 | 4 | 0.040 |
Why?
|
| Blister | 1 | 2020 | 88 | 0.040 |
Why?
|
| Asymptomatic Diseases | 1 | 2023 | 591 | 0.040 |
Why?
|
| Managed Care Programs | 2 | 2004 | 941 | 0.040 |
Why?
|
| Exercise Test | 2 | 2004 | 2186 | 0.040 |
Why?
|
| Hospitals, University | 1 | 2002 | 569 | 0.040 |
Why?
|
| Macrophages | 1 | 2015 | 5797 | 0.040 |
Why?
|
| Gastrointestinal Transit | 1 | 2001 | 101 | 0.040 |
Why?
|
| Bottle Feeding | 1 | 2000 | 67 | 0.040 |
Why?
|
| Fetal Distress | 1 | 2019 | 39 | 0.040 |
Why?
|
| Epithelium | 2 | 2022 | 1610 | 0.040 |
Why?
|
| Tumor Microenvironment | 2 | 2024 | 3939 | 0.040 |
Why?
|
| Upper Extremity | 1 | 2005 | 683 | 0.040 |
Why?
|
| DNA Helicases | 1 | 2005 | 853 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 4 | 2004 | 5803 | 0.040 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2015 | 3623 | 0.040 |
Why?
|
| Talc | 1 | 2000 | 48 | 0.040 |
Why?
|
| Somatomedins | 1 | 2000 | 179 | 0.040 |
Why?
|
| Lighting | 1 | 2001 | 211 | 0.040 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2002 | 423 | 0.040 |
Why?
|
| Organizational Case Studies | 2 | 2016 | 301 | 0.040 |
Why?
|
| Rats | 1 | 2016 | 23839 | 0.040 |
Why?
|
| Intestinal Polyps | 2 | 1997 | 105 | 0.040 |
Why?
|
| Carcinoma in Situ | 1 | 2005 | 791 | 0.040 |
Why?
|
| Skinfold Thickness | 1 | 1999 | 163 | 0.040 |
Why?
|
| Brain Death | 1 | 2023 | 360 | 0.040 |
Why?
|
| Length of Stay | 4 | 2019 | 6521 | 0.040 |
Why?
|
| Tobacco, Smokeless | 1 | 2000 | 134 | 0.040 |
Why?
|
| Delivery Rooms | 1 | 2019 | 38 | 0.040 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2001 | 289 | 0.040 |
Why?
|
| Membrane Proteins | 2 | 2014 | 7895 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 4 | 2004 | 6087 | 0.040 |
Why?
|
| Diagnostic Imaging | 1 | 2013 | 3543 | 0.040 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2024 | 757 | 0.040 |
Why?
|
| Keratoacanthoma | 1 | 1979 | 33 | 0.040 |
Why?
|
| Self Disclosure | 2 | 2002 | 249 | 0.040 |
Why?
|
| Radiography | 5 | 2012 | 6995 | 0.040 |
Why?
|
| Zinc | 1 | 2003 | 677 | 0.040 |
Why?
|
| Transcription Factors | 3 | 2005 | 12176 | 0.040 |
Why?
|
| Contraceptives, Oral, Combined | 2 | 1997 | 117 | 0.040 |
Why?
|
| Weather | 1 | 2020 | 232 | 0.040 |
Why?
|
| Cysteine | 1 | 2003 | 895 | 0.040 |
Why?
|
| Videotape Recording | 1 | 2020 | 336 | 0.040 |
Why?
|
| Uncertainty | 1 | 2004 | 758 | 0.040 |
Why?
|
| Transcriptional Elongation Factors | 1 | 2020 | 167 | 0.040 |
Why?
|
| Germ Cells | 1 | 2022 | 641 | 0.040 |
Why?
|
| Hawaii | 1 | 2018 | 101 | 0.040 |
Why?
|
| Social Facilitation | 2 | 2008 | 31 | 0.040 |
Why?
|
| Fathers | 1 | 2001 | 377 | 0.040 |
Why?
|
| Skin Pigmentation | 4 | 2006 | 278 | 0.040 |
Why?
|
| Wine | 4 | 2004 | 172 | 0.040 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2004 | 2538 | 0.040 |
Why?
|
| Referral and Consultation | 2 | 2023 | 3629 | 0.040 |
Why?
|
| Leadership | 2 | 2020 | 1395 | 0.040 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2001 | 352 | 0.040 |
Why?
|
| Hip Prosthesis | 2 | 1995 | 924 | 0.040 |
Why?
|
| Paraproteinemias | 1 | 2001 | 254 | 0.040 |
Why?
|
| Karyotyping | 1 | 2020 | 1173 | 0.040 |
Why?
|
| Medically Uninsured | 2 | 2020 | 841 | 0.040 |
Why?
|
| Genital Diseases, Female | 1 | 2019 | 193 | 0.040 |
Why?
|
| Absenteeism | 1 | 1999 | 247 | 0.040 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 1998 | 89 | 0.040 |
Why?
|
| Peroxidase | 1 | 2001 | 610 | 0.040 |
Why?
|
| Disease Outbreaks | 1 | 2007 | 1763 | 0.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 863 | 0.040 |
Why?
|
| Preceptorship | 1 | 1978 | 56 | 0.040 |
Why?
|
| Controlled Clinical Trials as Topic | 1 | 1998 | 187 | 0.040 |
Why?
|
| Rest | 1 | 2003 | 952 | 0.040 |
Why?
|
| Geographic Information Systems | 1 | 2020 | 283 | 0.040 |
Why?
|
| Comparative Effectiveness Research | 2 | 2014 | 712 | 0.040 |
Why?
|
| Botulinum Toxins | 1 | 2019 | 189 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2008 | 2785 | 0.040 |
Why?
|
| Arthralgia | 1 | 2022 | 462 | 0.040 |
Why?
|
| Colorado | 1 | 2018 | 166 | 0.040 |
Why?
|
| Adaptation, Psychological | 2 | 2020 | 2664 | 0.040 |
Why?
|
| Social Isolation | 1 | 2001 | 369 | 0.040 |
Why?
|
| Pyridoxine | 1 | 1998 | 109 | 0.040 |
Why?
|
| Contraception | 2 | 2007 | 362 | 0.040 |
Why?
|
| Seafood | 1 | 2001 | 395 | 0.040 |
Why?
|
| Work | 1 | 1998 | 195 | 0.040 |
Why?
|
| Societies, Scientific | 1 | 2018 | 223 | 0.040 |
Why?
|
| Amniotic Fluid | 1 | 2019 | 381 | 0.040 |
Why?
|
| Inservice Training | 1 | 2020 | 377 | 0.040 |
Why?
|
| Maryland | 1 | 2017 | 277 | 0.040 |
Why?
|
| Mutation, Missense | 2 | 2003 | 2590 | 0.040 |
Why?
|
| Urinary Bladder | 1 | 2023 | 1160 | 0.040 |
Why?
|
| Propensity Score | 2 | 2016 | 1970 | 0.040 |
Why?
|
| Treatment Failure | 1 | 2003 | 2655 | 0.040 |
Why?
|
| Diuretics | 2 | 1998 | 612 | 0.040 |
Why?
|
| Ideal Body Weight | 1 | 2016 | 27 | 0.030 |
Why?
|
| Dihydroergotamine | 2 | 1987 | 19 | 0.030 |
Why?
|
| Goals | 2 | 2019 | 715 | 0.030 |
Why?
|
| Electrophysiology | 1 | 2000 | 1266 | 0.030 |
Why?
|
| Lower Extremity | 1 | 2005 | 1214 | 0.030 |
Why?
|
| Professional Competence | 1 | 2000 | 431 | 0.030 |
Why?
|
| Geriatrics | 1 | 1981 | 390 | 0.030 |
Why?
|
| Ovulation Induction | 1 | 2019 | 277 | 0.030 |
Why?
|
| Oxidoreductases Acting on CH-NH Group Donors | 1 | 1996 | 62 | 0.030 |
Why?
|
| Menstruation | 3 | 2005 | 310 | 0.030 |
Why?
|
| Markov Chains | 2 | 2000 | 977 | 0.030 |
Why?
|
| Amines | 1 | 1998 | 280 | 0.030 |
Why?
|
| Hip Dislocation | 1 | 2019 | 249 | 0.030 |
Why?
|
| Radiosurgery | 2 | 2016 | 1354 | 0.030 |
Why?
|
| Rectum | 2 | 2019 | 902 | 0.030 |
Why?
|
| Cephalometry | 1 | 1998 | 379 | 0.030 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2023 | 1226 | 0.030 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1996 | 174 | 0.030 |
Why?
|
| Transmembrane Activator and CAML Interactor Protein | 1 | 2016 | 55 | 0.030 |
Why?
|
| Equipment and Supplies | 1 | 1999 | 273 | 0.030 |
Why?
|
| Immune System Diseases | 1 | 1999 | 255 | 0.030 |
Why?
|
| United States Environmental Protection Agency | 1 | 1996 | 139 | 0.030 |
Why?
|
| Papillomaviridae | 1 | 2022 | 1135 | 0.030 |
Why?
|
| Aftercare | 1 | 2022 | 921 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2021 | 2488 | 0.030 |
Why?
|
| Connective Tissue Diseases | 2 | 1999 | 285 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2004 | 1795 | 0.030 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2017 | 216 | 0.030 |
Why?
|
| Cotinine | 1 | 1996 | 207 | 0.030 |
Why?
|
| Physical Examination | 1 | 2002 | 1262 | 0.030 |
Why?
|
| Physical Therapy Modalities | 1 | 2019 | 533 | 0.030 |
Why?
|
| Fructose | 1 | 1998 | 285 | 0.030 |
Why?
|
| School Health Services | 1 | 1999 | 389 | 0.030 |
Why?
|
| Finasteride | 1 | 1996 | 86 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2024 | 1760 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2006 | 2964 | 0.030 |
Why?
|
| Cerebral Hemorrhage | 4 | 2001 | 2665 | 0.030 |
Why?
|
| Pregnancy Rate | 1 | 2019 | 655 | 0.030 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2021 | 1794 | 0.030 |
Why?
|
| Sodium, Dietary | 2 | 1997 | 427 | 0.030 |
Why?
|
| Drinking Behavior | 1 | 1996 | 103 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2024 | 2046 | 0.030 |
Why?
|
| Food, Fortified | 1 | 1996 | 189 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2024 | 2575 | 0.030 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2018 | 692 | 0.030 |
Why?
|
| Pulmonary Ventilation | 1 | 1997 | 377 | 0.030 |
Why?
|
| Phlebotomy | 1 | 2016 | 138 | 0.030 |
Why?
|
| Time | 1 | 1997 | 546 | 0.030 |
Why?
|
| Drug Storage | 1 | 1995 | 52 | 0.030 |
Why?
|
| Spouses | 3 | 2003 | 286 | 0.030 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2016 | 190 | 0.030 |
Why?
|
| Calcium Channel Blockers | 1 | 1998 | 692 | 0.030 |
Why?
|
| Live Birth | 1 | 2019 | 516 | 0.030 |
Why?
|
| Diverticulum, Colon | 1 | 1995 | 32 | 0.030 |
Why?
|
| Glutathione Transferase | 1 | 1997 | 567 | 0.030 |
Why?
|
| Trace Elements | 1 | 1996 | 193 | 0.030 |
Why?
|
| Genomics | 2 | 2023 | 5912 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2020 | 1833 | 0.030 |
Why?
|
| Procollagen | 1 | 2015 | 189 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2018 | 1585 | 0.030 |
Why?
|
| Electric Impedance | 1 | 1999 | 796 | 0.030 |
Why?
|
| Housing | 1 | 1999 | 679 | 0.030 |
Why?
|
| Meningioma | 1 | 2003 | 1222 | 0.030 |
Why?
|
| Physical Endurance | 1 | 1997 | 370 | 0.030 |
Why?
|
| Hospitals, Teaching | 1 | 1979 | 1158 | 0.030 |
Why?
|
| Social Conformity | 1 | 1994 | 39 | 0.030 |
Why?
|
| Prostate | 1 | 2023 | 1781 | 0.030 |
Why?
|
| Subarachnoid Hemorrhage | 5 | 1999 | 1041 | 0.030 |
Why?
|
| Androstenedione | 2 | 2004 | 132 | 0.030 |
Why?
|
| Saliva | 1 | 2019 | 854 | 0.030 |
Why?
|
| Mycobacterium Infections | 1 | 1995 | 122 | 0.030 |
Why?
|
| Sexual Behavior | 1 | 2004 | 2200 | 0.030 |
Why?
|
| Lipids | 1 | 2005 | 3346 | 0.030 |
Why?
|
| Meningeal Neoplasms | 1 | 2003 | 1251 | 0.030 |
Why?
|
| Natural Language Processing | 1 | 2023 | 1197 | 0.030 |
Why?
|
| Anovulation | 1 | 1994 | 54 | 0.030 |
Why?
|
| Personality Assessment | 1 | 1996 | 649 | 0.030 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2018 | 1133 | 0.030 |
Why?
|
| Climate | 1 | 1995 | 148 | 0.030 |
Why?
|
| Sex Characteristics | 4 | 2005 | 2667 | 0.030 |
Why?
|
| Recurrence | 2 | 2015 | 8510 | 0.030 |
Why?
|
| Taxoids | 1 | 2017 | 669 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2022 | 1737 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2017 | 3813 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2020 | 2525 | 0.030 |
Why?
|
| Lactation | 2 | 2001 | 397 | 0.030 |
Why?
|
| Mice | 3 | 2016 | 82051 | 0.030 |
Why?
|
| Competency-Based Education | 1 | 2015 | 224 | 0.030 |
Why?
|
| Pepsinogen C | 1 | 2013 | 7 | 0.030 |
Why?
|
| Pepsinogen A | 1 | 2013 | 14 | 0.030 |
Why?
|
| Margarine | 1 | 1993 | 17 | 0.030 |
Why?
|
| Creatinine | 2 | 2013 | 1915 | 0.030 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2015 | 303 | 0.030 |
Why?
|
| Health Care Rationing | 1 | 1997 | 436 | 0.030 |
Why?
|
| Photic Stimulation | 1 | 2000 | 2005 | 0.030 |
Why?
|
| Gastrins | 1 | 2013 | 75 | 0.030 |
Why?
|
| Aneuploidy | 1 | 2017 | 572 | 0.030 |
Why?
|
| Cities | 1 | 2016 | 545 | 0.030 |
Why?
|
| Point-of-Care Systems | 1 | 2022 | 1227 | 0.030 |
Why?
|
| Daucus carota | 2 | 2005 | 11 | 0.030 |
Why?
|
| Health Occupations | 4 | 1999 | 225 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2017 | 1640 | 0.030 |
Why?
|
| Tissue Donors | 1 | 2023 | 2377 | 0.030 |
Why?
|
| Dinoprost | 1 | 2013 | 139 | 0.030 |
Why?
|
| Cicatrix | 1 | 1999 | 799 | 0.030 |
Why?
|
| Societies, Medical | 2 | 2018 | 3954 | 0.030 |
Why?
|
| Clone Cells | 1 | 2016 | 1672 | 0.030 |
Why?
|
| Spirituality | 1 | 2017 | 430 | 0.030 |
Why?
|
| Complementary Therapies | 1 | 2016 | 487 | 0.030 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2015 | 588 | 0.030 |
Why?
|
| Valine | 2 | 2004 | 410 | 0.030 |
Why?
|
| Nerve Block | 1 | 2019 | 711 | 0.030 |
Why?
|
| Fertility | 1 | 1997 | 772 | 0.030 |
Why?
|
| Chromosome Deletion | 1 | 1997 | 1390 | 0.030 |
Why?
|
| Arthritis, Rheumatoid | 4 | 2000 | 3762 | 0.030 |
Why?
|
| Femur | 1 | 1999 | 1311 | 0.030 |
Why?
|
| Risk Adjustment | 1 | 2016 | 603 | 0.030 |
Why?
|
| Zambia | 1 | 2013 | 273 | 0.030 |
Why?
|
| Toes | 4 | 1996 | 209 | 0.030 |
Why?
|
| Organizational Policy | 2 | 2007 | 434 | 0.030 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2013 | 353 | 0.030 |
Why?
|
| ROC Curve | 3 | 2009 | 3623 | 0.020 |
Why?
|
| Prostate-Specific Antigen | 1 | 2002 | 2483 | 0.020 |
Why?
|
| Pleurodesis | 1 | 2012 | 49 | 0.020 |
Why?
|
| Interprofessional Relations | 2 | 2012 | 997 | 0.020 |
Why?
|
| Keratin-6 | 1 | 2011 | 17 | 0.020 |
Why?
|
| Depressive Disorder | 2 | 2002 | 3738 | 0.020 |
Why?
|
| Collagen Type I | 1 | 2015 | 620 | 0.020 |
Why?
|
| Vincristine | 1 | 2014 | 1039 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2024 | 3111 | 0.020 |
Why?
|
| Hyperglycemia | 1 | 2020 | 1389 | 0.020 |
Why?
|
| Women | 1 | 1993 | 225 | 0.020 |
Why?
|
| Alanine | 2 | 2004 | 613 | 0.020 |
Why?
|
| Candy | 1 | 1991 | 36 | 0.020 |
Why?
|
| Cost Control | 2 | 2007 | 627 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2013 | 3793 | 0.020 |
Why?
|
| Thoracoscopy | 1 | 2012 | 186 | 0.020 |
Why?
|
| Treatment Refusal | 2 | 2009 | 432 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2022 | 4180 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2014 | 695 | 0.020 |
Why?
|
| Virulence | 1 | 1995 | 1301 | 0.020 |
Why?
|
| Germ-Line Mutation | 1 | 2019 | 1884 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2017 | 3635 | 0.020 |
Why?
|
| Telephone | 2 | 2012 | 630 | 0.020 |
Why?
|
| Biological Availability | 2 | 2004 | 390 | 0.020 |
Why?
|
| Gastrectomy | 1 | 2016 | 696 | 0.020 |
Why?
|
| Intrauterine Devices | 2 | 2007 | 117 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2024 | 4613 | 0.020 |
Why?
|
| Environment Design | 1 | 2012 | 174 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 1999 | 1669 | 0.020 |
Why?
|
| Temperance | 2 | 2001 | 88 | 0.020 |
Why?
|
| Cacao | 1 | 1991 | 98 | 0.020 |
Why?
|
| Species Specificity | 1 | 1995 | 2419 | 0.020 |
Why?
|
| Health Facilities | 1 | 2015 | 576 | 0.020 |
Why?
|
| Hazardous Substances | 1 | 2011 | 153 | 0.020 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2005 | 3198 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2017 | 17149 | 0.020 |
Why?
|
| Wounds and Injuries | 1 | 1983 | 2518 | 0.020 |
Why?
|
| Multifactorial Inheritance | 1 | 2018 | 1421 | 0.020 |
Why?
|
| Cultural Characteristics | 1 | 2011 | 250 | 0.020 |
Why?
|
| Point Mutation | 1 | 2015 | 1596 | 0.020 |
Why?
|
| Molecular Sequence Annotation | 1 | 2012 | 527 | 0.020 |
Why?
|
| Cimetidine | 1 | 1989 | 76 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2022 | 3697 | 0.020 |
Why?
|
| Iofetamine | 1 | 1989 | 14 | 0.020 |
Why?
|
| Emergency Medicine | 1 | 2019 | 1222 | 0.020 |
Why?
|
| Prednisone | 1 | 2014 | 1568 | 0.020 |
Why?
|
| Helicobacter pylori | 1 | 2013 | 382 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2017 | 2003 | 0.020 |
Why?
|
| Health Records, Personal | 1 | 2010 | 127 | 0.020 |
Why?
|
| Epidemiologic Research Design | 1 | 2013 | 368 | 0.020 |
Why?
|
| Oxygen | 1 | 2021 | 4269 | 0.020 |
Why?
|
| Quality Assurance, Health Care | 1 | 1979 | 2179 | 0.020 |
Why?
|
| Professional Role | 1 | 2012 | 316 | 0.020 |
Why?
|
| Sweden | 2 | 2005 | 1382 | 0.020 |
Why?
|
| Metabolomics | 1 | 2018 | 1675 | 0.020 |
Why?
|
| Histamine H2 Antagonists | 1 | 1990 | 169 | 0.020 |
Why?
|
| Drug Interactions | 2 | 2004 | 1421 | 0.020 |
Why?
|
| Psychotherapy, Group | 1 | 2012 | 414 | 0.020 |
Why?
|
| Clinical Competence | 2 | 2002 | 4841 | 0.020 |
Why?
|
| Immunity | 1 | 1995 | 1002 | 0.020 |
Why?
|
| Disabled Persons | 1 | 1998 | 1218 | 0.020 |
Why?
|
| Myocardial Ischemia | 1 | 1999 | 2139 | 0.020 |
Why?
|
| Graft Survival | 1 | 2019 | 3890 | 0.020 |
Why?
|
| Cyclophosphamide | 1 | 2014 | 2224 | 0.020 |
Why?
|
| Diagnosis, Differential | 3 | 1998 | 13025 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 6241 | 0.020 |
Why?
|
| Public Opinion | 1 | 2012 | 487 | 0.020 |
Why?
|
| Educational Measurement | 1 | 2015 | 1256 | 0.020 |
Why?
|
| Chicago | 1 | 2008 | 255 | 0.020 |
Why?
|
| Video Recording | 1 | 2013 | 974 | 0.020 |
Why?
|
| Surgical Flaps | 1 | 2017 | 1683 | 0.020 |
Why?
|
| Peptic Ulcer | 1 | 1989 | 222 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2012 | 1064 | 0.020 |
Why?
|
| Intellectual Property | 1 | 2007 | 32 | 0.020 |
Why?
|
| Hospitals | 1 | 2021 | 3906 | 0.020 |
Why?
|
| Rural Health Services | 1 | 2011 | 392 | 0.020 |
Why?
|
| Mexico | 2 | 2000 | 766 | 0.020 |
Why?
|
| Alzheimer Disease | 1 | 1989 | 8723 | 0.020 |
Why?
|
| Acute Disease | 2 | 2016 | 7245 | 0.020 |
Why?
|
| Hair Preparations | 1 | 1987 | 32 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2010 | 1706 | 0.020 |
Why?
|
| Castration | 1 | 1987 | 150 | 0.020 |
Why?
|
| Liver Transplantation | 1 | 2019 | 2399 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 1998 | 2723 | 0.020 |
Why?
|
| Escape Reaction | 1 | 2007 | 57 | 0.020 |
Why?
|
| Radiotherapy Dosage | 1 | 2014 | 2925 | 0.020 |
Why?
|
| DNA Primers | 2 | 2002 | 2825 | 0.020 |
Why?
|
| Information Management | 1 | 2007 | 100 | 0.020 |
Why?
|
| Anorexia Nervosa | 1 | 1996 | 1363 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2012 | 2633 | 0.020 |
Why?
|
| Double-Blind Method | 4 | 1989 | 12450 | 0.020 |
Why?
|
| Nevus, Pigmented | 1 | 1989 | 225 | 0.020 |
Why?
|
| Pain | 2 | 2000 | 5096 | 0.020 |
Why?
|
| Keratins | 1 | 2008 | 502 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2015 | 4834 | 0.020 |
Why?
|
| Stereoisomerism | 2 | 2001 | 612 | 0.020 |
Why?
|
| Human Experimentation | 1 | 2007 | 124 | 0.020 |
Why?
|
| Catheterization | 1 | 2012 | 1431 | 0.020 |
Why?
|
| Mammaplasty | 1 | 2017 | 1262 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 1999 | 3484 | 0.020 |
Why?
|
| DNA, Neoplasm | 2 | 2003 | 1749 | 0.020 |
Why?
|
| Drug Prescriptions | 1 | 1996 | 1677 | 0.020 |
Why?
|
| Hydrocortisone | 1 | 1994 | 1836 | 0.020 |
Why?
|
| Warfarin | 1 | 1995 | 1493 | 0.020 |
Why?
|
| Commerce | 2 | 2006 | 613 | 0.020 |
Why?
|
| Iron | 1 | 1995 | 1813 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 2007 | 862 | 0.020 |
Why?
|
| Leukemia | 1 | 1994 | 1527 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2011 | 1503 | 0.020 |
Why?
|
| Contraceptive Agents, Female | 1 | 2007 | 121 | 0.020 |
Why?
|
| Administration, Cutaneous | 1 | 1988 | 716 | 0.020 |
Why?
|
| Chi-Square Distribution | 2 | 2006 | 3438 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 1996 | 3734 | 0.020 |
Why?
|
| Negotiating | 1 | 2007 | 152 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2017 | 2834 | 0.020 |
Why?
|
| Lymphoma, Follicular | 1 | 2010 | 460 | 0.020 |
Why?
|
| Root Canal Therapy | 1 | 2006 | 65 | 0.020 |
Why?
|
| Pyrus | 1 | 2005 | 13 | 0.020 |
Why?
|
| HIV | 1 | 2013 | 1587 | 0.020 |
Why?
|
| Disclosure | 1 | 2011 | 750 | 0.020 |
Why?
|
| Nanoparticles | 1 | 2017 | 1986 | 0.020 |
Why?
|
| Glucose | 1 | 2017 | 4355 | 0.020 |
Why?
|
| Architectural Accessibility | 1 | 2005 | 24 | 0.020 |
Why?
|
| Color | 1 | 2006 | 297 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2016 | 2987 | 0.020 |
Why?
|
| Medicare | 1 | 2024 | 6880 | 0.020 |
Why?
|
| Canada | 1 | 2011 | 2143 | 0.020 |
Why?
|
| Asia | 1 | 2007 | 627 | 0.020 |
Why?
|
| Xeroderma Pigmentosum Group D Protein | 1 | 2005 | 106 | 0.020 |
Why?
|
| Censuses | 1 | 2006 | 198 | 0.020 |
Why?
|
| Malus | 1 | 2005 | 51 | 0.020 |
Why?
|
| Proteomics | 1 | 2018 | 3901 | 0.010 |
Why?
|
| Androstenols | 1 | 2004 | 25 | 0.010 |
Why?
|
| Placebos | 1 | 1989 | 1668 | 0.010 |
Why?
|
| Social Marketing | 1 | 2004 | 52 | 0.010 |
Why?
|
| Waist-Hip Ratio | 1 | 2006 | 520 | 0.010 |
Why?
|
| Gastrointestinal Diseases | 2 | 1990 | 1207 | 0.010 |
Why?
|
| Estrogens, Catechol | 1 | 2004 | 25 | 0.010 |
Why?
|
| Glucuronides | 1 | 2004 | 20 | 0.010 |
Why?
|
| UTP-Hexose-1-Phosphate Uridylyltransferase | 1 | 2004 | 68 | 0.010 |
Why?
|
| DNA Ligases | 1 | 2004 | 82 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2022 | 11674 | 0.010 |
Why?
|
| Endocrinology | 1 | 2010 | 443 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2012 | 2393 | 0.010 |
Why?
|
| Dental Care | 2 | 1998 | 285 | 0.010 |
Why?
|
| Seasons | 1 | 1990 | 1526 | 0.010 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2019 | 3682 | 0.010 |
Why?
|
| Interpersonal Relations | 2 | 2000 | 1439 | 0.010 |
Why?
|
| Pressure | 1 | 1987 | 1173 | 0.010 |
Why?
|
| Jaw, Edentulous, Partially | 1 | 2004 | 84 | 0.010 |
Why?
|
| Likelihood Functions | 2 | 1999 | 993 | 0.010 |
Why?
|
| Radiation Dosage | 1 | 2012 | 1974 | 0.010 |
Why?
|
| Homozygote | 1 | 2008 | 1779 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2004 | 348 | 0.010 |
Why?
|
| Time and Motion Studies | 1 | 2003 | 143 | 0.010 |
Why?
|
| Ataxia Telangiectasia | 1 | 2004 | 107 | 0.010 |
Why?
|
| Genes, Recessive | 1 | 2006 | 625 | 0.010 |
Why?
|
| Mitomycin | 1 | 2004 | 264 | 0.010 |
Why?
|
| Intergenerational Relations | 1 | 2003 | 68 | 0.010 |
Why?
|
| Jaw, Edentulous | 1 | 2004 | 96 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 1999 | 3439 | 0.010 |
Why?
|
| Peptides | 1 | 2015 | 4368 | 0.010 |
Why?
|
| Solar System | 1 | 2002 | 12 | 0.010 |
Why?
|
| Leucine | 1 | 2004 | 549 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2016 | 4213 | 0.010 |
Why?
|
| Vaginal Smears | 1 | 2006 | 501 | 0.010 |
Why?
|
| Rad52 DNA Repair and Recombination Protein | 1 | 2002 | 27 | 0.010 |
Why?
|
| Arginine | 1 | 2006 | 923 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2015 | 5151 | 0.010 |
Why?
|
| Homosexuality, Female | 1 | 2004 | 171 | 0.010 |
Why?
|
| Disease Management | 1 | 2013 | 2533 | 0.010 |
Why?
|
| Neoadjuvant Therapy | 1 | 2014 | 2896 | 0.010 |
Why?
|
| Bisexuality | 1 | 2004 | 294 | 0.010 |
Why?
|
| Factor Analysis, Statistical | 1 | 2005 | 1007 | 0.010 |
Why?
|
| Radiation Protection | 1 | 2006 | 428 | 0.010 |
Why?
|
| Computational Biology | 1 | 2014 | 3549 | 0.010 |
Why?
|
| Lung Diseases | 2 | 1989 | 1926 | 0.010 |
Why?
|
| Skin | 1 | 2016 | 4520 | 0.010 |
Why?
|
| Barium Sulfate | 1 | 2002 | 180 | 0.010 |
Why?
|
| Dental Caries | 1 | 2006 | 429 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 7467 | 0.010 |
Why?
|
| Enema | 1 | 2002 | 141 | 0.010 |
Why?
|
| Consultants | 1 | 1981 | 57 | 0.010 |
Why?
|
| Heart Rate | 2 | 1996 | 4218 | 0.010 |
Why?
|
| State Government | 1 | 2004 | 389 | 0.010 |
Why?
|
| Personality Inventory | 1 | 2004 | 1019 | 0.010 |
Why?
|
| Emotions | 1 | 2013 | 2772 | 0.010 |
Why?
|
| DDT | 1 | 2001 | 32 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2011 | 3663 | 0.010 |
Why?
|
| Sickness Impact Profile | 1 | 2002 | 299 | 0.010 |
Why?
|
| Myeloblastin | 1 | 2001 | 101 | 0.010 |
Why?
|
| Endometrium | 1 | 2004 | 407 | 0.010 |
Why?
|
| Diazepam | 1 | 2002 | 215 | 0.010 |
Why?
|
| Thrombosis | 1 | 1995 | 2954 | 0.010 |
Why?
|
| Decision Trees | 2 | 1995 | 510 | 0.010 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2001 | 284 | 0.010 |
Why?
|
| Rhode Island | 1 | 2001 | 353 | 0.010 |
Why?
|
| Churg-Strauss Syndrome | 1 | 2001 | 75 | 0.010 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2005 | 388 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2006 | 1629 | 0.010 |
Why?
|
| Nuclear Receptor Coactivator 3 | 1 | 2000 | 46 | 0.010 |
Why?
|
| Monitoring, Ambulatory | 1 | 2004 | 357 | 0.010 |
Why?
|
| Antitubercular Agents | 2 | 2001 | 1390 | 0.010 |
Why?
|
| Nurse Practitioners | 1 | 2004 | 271 | 0.010 |
Why?
|
| Life Tables | 1 | 2000 | 368 | 0.010 |
Why?
|
| Intestines | 1 | 1989 | 1912 | 0.010 |
Why?
|
| Alveolar Bone Loss | 1 | 2004 | 399 | 0.010 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2004 | 389 | 0.010 |
Why?
|
| Lens, Crystalline | 1 | 2002 | 387 | 0.010 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2003 | 371 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2014 | 4425 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2004 | 1775 | 0.010 |
Why?
|
| Folic Acid Deficiency | 1 | 2000 | 117 | 0.010 |
Why?
|
| Specimen Handling | 1 | 2004 | 709 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 1987 | 1282 | 0.010 |
Why?
|
| Tropical Climate | 1 | 1979 | 35 | 0.010 |
Why?
|
| Genomic Imprinting | 1 | 2001 | 324 | 0.010 |
Why?
|
| Glomerulonephritis | 1 | 2001 | 333 | 0.010 |
Why?
|
| Anti-Anxiety Agents | 1 | 2002 | 405 | 0.010 |
Why?
|
| Acetaminophen | 1 | 2003 | 556 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 2 | 2000 | 4774 | 0.010 |
Why?
|
| Internship and Residency | 1 | 1979 | 5952 | 0.010 |
Why?
|
| Baltimore | 1 | 1999 | 234 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 22365 | 0.010 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2000 | 219 | 0.010 |
Why?
|
| Muscle Tonus | 1 | 1998 | 82 | 0.010 |
Why?
|
| Perineum | 1 | 2000 | 210 | 0.010 |
Why?
|
| England | 1 | 1980 | 533 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2018 | 7955 | 0.010 |
Why?
|
| Nervous System Diseases | 1 | 1989 | 1668 | 0.010 |
Why?
|
| Hyperinsulinism | 1 | 2001 | 401 | 0.010 |
Why?
|
| Oral Health | 1 | 2004 | 494 | 0.010 |
Why?
|
| Axilla | 1 | 2001 | 629 | 0.010 |
Why?
|
| Child Rearing | 1 | 1978 | 74 | 0.010 |
Why?
|
| Cell Line | 1 | 2012 | 15610 | 0.010 |
Why?
|
| Personnel Selection | 1 | 1980 | 201 | 0.010 |
Why?
|
| Periodicity | 1 | 1999 | 348 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2006 | 2942 | 0.010 |
Why?
|
| Buttocks | 1 | 1998 | 112 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2002 | 1706 | 0.010 |
Why?
|
| Introns | 1 | 2000 | 971 | 0.010 |
Why?
|
| Empathy | 1 | 1982 | 476 | 0.010 |
Why?
|
| Transcription, Genetic | 2 | 2002 | 7602 | 0.010 |
Why?
|
| Malpractice | 1 | 2002 | 561 | 0.010 |
Why?
|
| Glutamine | 1 | 2000 | 578 | 0.010 |
Why?
|
| Dopamine | 1 | 2004 | 1616 | 0.010 |
Why?
|
| Oral Hygiene | 1 | 1998 | 132 | 0.010 |
Why?
|
| Plasma | 1 | 2000 | 586 | 0.010 |
Why?
|
| Ethics, Medical | 1 | 1982 | 785 | 0.010 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2001 | 526 | 0.010 |
Why?
|
| Chickens | 1 | 1999 | 860 | 0.010 |
Why?
|
| Apoptosis | 2 | 2006 | 9526 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2005 | 2889 | 0.010 |
Why?
|
| Homosexuality, Male | 1 | 2004 | 1343 | 0.010 |
Why?
|
| Serine Endopeptidases | 1 | 2001 | 1032 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2006 | 3442 | 0.010 |
Why?
|
| Emergencies | 1 | 1982 | 1222 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2006 | 2882 | 0.010 |
Why?
|
| Sympathetic Nervous System | 1 | 1998 | 521 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 1995 | 18390 | 0.010 |
Why?
|
| Brain Ischemia | 3 | 1997 | 3038 | 0.010 |
Why?
|
| Cholesterol, HDL | 2 | 1993 | 1820 | 0.010 |
Why?
|
| Stress, Physiological | 1 | 2003 | 1409 | 0.010 |
Why?
|
| Environmental Pollution | 1 | 1996 | 125 | 0.010 |
Why?
|
| Acetylation | 1 | 1997 | 1054 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 6135 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 1998 | 930 | 0.010 |
Why?
|
| Phosphates | 1 | 1998 | 767 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2017 | 23639 | 0.010 |
Why?
|
| Docosahexaenoic Acids | 1 | 2001 | 907 | 0.010 |
Why?
|
| Dihydrotestosterone | 1 | 1994 | 195 | 0.010 |
Why?
|
| Cell Survival | 1 | 2004 | 5800 | 0.010 |
Why?
|
| Task Performance and Analysis | 1 | 1978 | 771 | 0.010 |
Why?
|
| Self Efficacy | 1 | 1998 | 651 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2004 | 2819 | 0.010 |
Why?
|
| Students | 1 | 2004 | 1751 | 0.010 |
Why?
|
| Prefrontal Cortex | 1 | 2004 | 2251 | 0.010 |
Why?
|
| Hydrogenation | 1 | 1993 | 20 | 0.010 |
Why?
|
| Myocardial Revascularization | 1 | 1997 | 796 | 0.010 |
Why?
|
| Economics, Pharmaceutical | 1 | 1994 | 88 | 0.010 |
Why?
|
| DNA | 1 | 2007 | 7213 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 1998 | 1244 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2004 | 3464 | 0.010 |
Why?
|
| Vomiting | 1 | 1996 | 655 | 0.010 |
Why?
|
| Potassium, Dietary | 1 | 1992 | 103 | 0.010 |
Why?
|
| Learning | 1 | 1982 | 1762 | 0.010 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 1990 | 1126 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2001 | 1898 | 0.010 |
Why?
|
| Condoms | 1 | 1994 | 338 | 0.010 |
Why?
|
| Riboflavin | 1 | 1992 | 107 | 0.010 |
Why?
|
| Estradiol Congeners | 1 | 1991 | 23 | 0.010 |
Why?
|
| Adrenal Glands | 1 | 1994 | 557 | 0.010 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 1998 | 1518 | 0.010 |
Why?
|
| Base Sequence | 1 | 2002 | 12426 | 0.010 |
Why?
|
| Photosensitivity Disorders | 1 | 1991 | 79 | 0.010 |
Why?
|
| Terminal Care | 1 | 1983 | 1773 | 0.010 |
Why?
|
| Obstetrics | 1 | 1978 | 676 | 0.010 |
Why?
|
| Methylation | 1 | 1993 | 1077 | 0.010 |
Why?
|
| Virus Diseases | 1 | 1996 | 722 | 0.010 |
Why?
|
| Sampling Studies | 1 | 1991 | 617 | 0.010 |
Why?
|
| Communicable Disease Control | 1 | 1996 | 857 | 0.010 |
Why?
|
| Postal Service | 1 | 1990 | 96 | 0.010 |
Why?
|
| Autoantibodies | 1 | 1999 | 2131 | 0.010 |
Why?
|
| Fasting | 1 | 1996 | 1608 | 0.010 |
Why?
|
| Soil | 1 | 1990 | 118 | 0.010 |
Why?
|
| Electrocoagulation | 1 | 1989 | 153 | 0.000 |
Why?
|
| Mental Disorders | 1 | 1989 | 6879 | 0.000 |
Why?
|
| Vaccination | 1 | 2001 | 3433 | 0.000 |
Why?
|
| Contrast Media | 1 | 2002 | 5337 | 0.000 |
Why?
|
| Tea | 1 | 1990 | 290 | 0.000 |
Why?
|
| Swine | 1 | 1999 | 5996 | 0.000 |
Why?
|
| Tuberculosis, Multidrug-Resistant | 1 | 1996 | 938 | 0.000 |
Why?
|
| Diverticulum | 1 | 1989 | 137 | 0.000 |
Why?
|
| Coronary Artery Bypass | 1 | 1997 | 2194 | 0.000 |
Why?
|
| Insulin Resistance | 1 | 2001 | 3974 | 0.000 |
Why?
|
| Linoleic Acids | 1 | 1987 | 39 | 0.000 |
Why?
|
| General Surgery | 1 | 1978 | 1714 | 0.000 |
Why?
|
| Intestinal Obstruction | 1 | 1990 | 435 | 0.000 |
Why?
|
| Arm | 1 | 1989 | 590 | 0.000 |
Why?
|
| Death, Sudden, Cardiac | 1 | 1994 | 1568 | 0.000 |
Why?
|
| Linoleic Acid | 1 | 1987 | 159 | 0.000 |
Why?
|
| Ultrasonography | 1 | 1998 | 5994 | 0.000 |
Why?
|
| Central Nervous System Diseases | 1 | 1989 | 521 | 0.000 |
Why?
|
| Insulin | 1 | 1999 | 6606 | 0.000 |
Why?
|
| Food Supply | 1 | 1990 | 543 | 0.000 |
Why?
|
| Leg | 1 | 1989 | 1089 | 0.000 |
Why?
|
| Deglutition Disorders | 1 | 1990 | 637 | 0.000 |
Why?
|
| Antidepressive Agents | 1 | 1996 | 2913 | 0.000 |
Why?
|
| Cholesterol, LDL | 1 | 1993 | 2396 | 0.000 |
Why?
|
| Extremities | 1 | 1988 | 870 | 0.000 |
Why?
|
| Pulmonary Emphysema | 1 | 1984 | 690 | 0.000 |
Why?
|
| Personal Satisfaction | 1 | 1982 | 648 | 0.000 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 1989 | 2444 | 0.000 |
Why?
|
| HIV Infections | 1 | 1996 | 17492 | 0.000 |
Why?
|